| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | NID2 HSPG2 RELN MATN2 EFEMP2 LAMA1 LAMA3 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 SSPOP FBLN2 FBN2 MEGF9 LTBP1 LTBP2 LTBP4 MUC5AC | 2.31e-21 | 188 | 133 | 22 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | SELL NID2 HSPG2 MATN2 EFEMP2 DNER CRELD2 MATN4 VWCE DLL1 LRP1B F7 LDLR F10 STAB1 SCUBE1 FBLN2 FBN2 PROZ EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 SYT13 NOTCH1 NOTCH2 NOTCH3 PROC | 2.05e-17 | 749 | 133 | 32 | GO:0005509 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.99e-14 | 114 | 133 | 14 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.84e-14 | 124 | 133 | 14 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.98e-13 | 137 | 133 | 14 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.04e-11 | 192 | 133 | 14 | GO:0008234 |
| GeneOntologyMolecularFunction | structural molecule activity | NID2 HSPG2 RELN COPA MATN2 EFEMP2 LAMA1 OBSCN LAMA3 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 SSPOP FBLN2 FBN2 MEGF9 JAG1 CSRP2 LTBP1 LTBP2 LTBP4 MUC5AC | 1.71e-10 | 891 | 133 | 26 | GO:0005198 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 RELN USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 F7 F10 USP17L18 MST1 PROZ USP17L17 FURIN USP17L6P ADAMTS20 USP17L22 USP17L15 PROC USP17L13 | 3.79e-10 | 654 | 133 | 22 | GO:0008233 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.01e-08 | 16 | 133 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.43e-07 | 60 | 133 | 7 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.60e-07 | 61 | 133 | 7 | GO:0098531 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.27e-07 | 21 | 133 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | Notch binding | 8.72e-07 | 27 | 133 | 5 | GO:0005112 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 8.93e-07 | 12 | 133 | 4 | GO:0030023 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.28e-06 | 13 | 133 | 4 | GO:0043208 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.59e-06 | 85 | 133 | 7 | GO:0038024 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.79e-06 | 14 | 133 | 4 | GO:0097493 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 2.90e-06 | 34 | 133 | 5 | GO:0046625 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 2.13e-05 | 25 | 133 | 4 | GO:0003707 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 4.58e-05 | 11 | 133 | 3 | GO:0034056 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF585A NR4A2 NR4A3 E2F5 NR4A1 NR3C1 PGR ZNF585B RLF PRDM15 NR1I3 NOTCH1 NOTCH2 | 1.06e-04 | 566 | 133 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.27e-04 | 73 | 133 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 1.32e-04 | 3 | 133 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | integrin binding | 1.73e-04 | 175 | 133 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 3.03e-04 | 20 | 133 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.16e-04 | 49 | 133 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF585A NR4A2 NR4A3 NR4A1 NR3C1 PGR ZNF585B RLF PRDM15 NR1I3 NOTCH1 NOTCH2 | 3.71e-04 | 560 | 133 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.38e-04 | 268 | 133 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.80e-04 | 207 | 133 | 7 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 5.54e-04 | 212 | 133 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | microfibril binding | 6.49e-04 | 6 | 133 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 7.52e-04 | 27 | 133 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF573 ZNF585A NR4A2 NR4A3 ZNF397 E2F5 NR4A1 NR3C1 KDM6B PGR ZNF585B ZNF648 NR3C2 ZNF333 PRDM15 NR1I3 NOTCH1 NOTCH2 ZNF286A | 7.64e-04 | 1271 | 133 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 9.30e-04 | 29 | 133 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF573 ZNF585A NR4A2 NR4A3 ZNF397 E2F5 ZNF57 NR4A1 NR3C1 PGR ZNF585B RLF ZNF648 NR3C2 ZNF333 PRDM15 NR1I3 NOTCH1 NOTCH2 ZNF286A | 1.07e-03 | 1412 | 133 | 20 | GO:0000981 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.73e-03 | 190 | 133 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.90e-03 | 37 | 133 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.22e-03 | 39 | 133 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SELL OBSCN NTNG1 LAMA5 LAMB1 LAMB2 ITGB5 ITGBL1 TNR LTBP4 NOTCH3 | 2.25e-03 | 599 | 133 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | lipid binding | SELL LAMA1 OBSCN LAMB1 LAMC1 NR4A1 NR3C1 F10 PGR ZCCHC14 JAG1 OSBPL9 NR3C2 TNR SYT13 | 2.43e-03 | 988 | 133 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | zinc ion binding | NR4A2 NR4A3 CHD3 CHD4 NR4A1 NR3C1 ZFAND4 PGR CNBP ZCCHC14 ADAMTS20 NR3C2 NR1I3 SEC23B | 2.49e-03 | 891 | 133 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | myosin II binding | 3.27e-03 | 13 | 133 | 2 | GO:0045159 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 3.27e-03 | 13 | 133 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 3.66e-03 | 547 | 133 | 10 | GO:0048018 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF573 ZNF585A NR4A2 NR4A3 ZNF397 E2F5 ZNF57 NR4A1 NR3C1 KDM6B BCOR PGR ZNF585B ZNF648 NR3C2 ZNF333 PRDM15 NR1I3 ZNF286A | 3.70e-03 | 1459 | 133 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF573 ZNF585A NR4A2 NR4A3 ZNF397 E2F5 NR4A1 NR3C1 KDM6B PGR ZNF585B ZNF648 NR3C2 ZNF333 PRDM15 NR1I3 ZNF286A | 3.74e-03 | 1244 | 133 | 17 | GO:0000978 |
| GeneOntologyMolecularFunction | growth factor binding | 3.94e-03 | 156 | 133 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 4.00e-03 | 554 | 133 | 10 | GO:0030546 | |
| GeneOntologyMolecularFunction | hormone binding | 5.00e-03 | 103 | 133 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 5.59e-03 | 54 | 133 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | growth factor activity | 6.08e-03 | 173 | 133 | 5 | GO:0008083 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 6.28e-03 | 18 | 133 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | protease binding | 7.32e-03 | 181 | 133 | 5 | GO:0002020 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 7.73e-03 | 20 | 133 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 8.25e-03 | 616 | 133 | 10 | GO:0030545 | |
| GeneOntologyMolecularFunction | clathrin binding | 8.57e-03 | 63 | 133 | 3 | GO:0030276 | |
| GeneOntologyBiologicalProcess | axon guidance | SEMA4F HSPG2 RELN MATN2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 9.66e-17 | 285 | 130 | 21 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | SEMA4F HSPG2 RELN MATN2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 1.04e-16 | 286 | 130 | 21 | GO:0097485 |
| GeneOntologyBiologicalProcess | axon development | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 GRN NTN4 MEGF8 MEGF9 CSPG5 CNTNAP2 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 3.56e-15 | 642 | 130 | 27 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 CNTNAP2 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 1.42e-14 | 566 | 130 | 25 | GO:0007409 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 5.18e-14 | 125 | 130 | 14 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.76e-13 | 144 | 130 | 14 | GO:0070646 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 CNTNAP2 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 6.90e-12 | 748 | 130 | 25 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 CSPG5 CNTNAP2 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 9.39e-12 | 826 | 130 | 26 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 CNTNAP2 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 3.08e-11 | 802 | 130 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 CNTNAP2 LRP2 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 4.82e-11 | 819 | 130 | 25 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 GRN NR3C1 NTN4 MEGF8 MEGF9 CSPG5 CNTNAP2 LRP2 LRP6 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 1.38e-09 | 1285 | 130 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | NID2 HSPG2 MATN2 EFEMP2 LAMA1 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 NTN4 FURIN ADAMTS20 TNR LTBP4 NOTCH1 | 2.07e-09 | 377 | 130 | 16 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | NID2 HSPG2 MATN2 EFEMP2 LAMA1 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 NTN4 FURIN ADAMTS20 TNR LTBP4 NOTCH1 | 2.15e-09 | 378 | 130 | 16 | GO:0043062 |
| GeneOntologyBiologicalProcess | gliogenesis | RELN EPM2A MATN2 DNER LAMB1 LAMB2 GRN NR3C1 DLL1 LDLR CSPG5 CNTNAP2 LRP2 LRP6 NOTCH1 NOTCH2 EPHA4 | 2.18e-09 | 435 | 130 | 17 | GO:0042063 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | NID2 HSPG2 MATN2 EFEMP2 LAMA1 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 NTN4 FURIN ADAMTS20 TNR LTBP4 NOTCH1 | 2.23e-09 | 379 | 130 | 16 | GO:0045229 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 NTN4 MEGF8 MEGF9 CSPG5 CNTNAP2 LRP2 LRP6 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 5.48e-09 | 1194 | 130 | 27 | GO:0000902 |
| GeneOntologyBiologicalProcess | basement membrane organization | 8.96e-09 | 43 | 130 | 7 | GO:0071711 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 E2F5 NR3C1 BCOR DLL1 SLC40A1 PGR MST1 NTN4 FBN2 MEGF8 MEGF9 JAG1 LRP2 LRP6 NOTCH1 NOTCH2 | 1.97e-08 | 1269 | 130 | 27 | GO:0009887 |
| GeneOntologyBiologicalProcess | neuron development | SEMA4F HSPG2 RELN STXBP5 MATN2 LAMA1 NR4A2 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NR4A3 GRN NR3C1 NTN4 MEGF8 MEGF9 CSPG5 CNTNAP2 LRP2 LRP6 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 2.53e-08 | 1463 | 130 | 29 | GO:0048666 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | EFEMP2 LAMA1 LAMA5 LAMC1 NR4A3 NR3C1 KDM6B DLL1 ITGB5 PGR MST1 NTN4 EGF MEGF8 JAG1 LRP2 LRP6 NOTCH1 NOTCH2 EPHA4 | 4.94e-08 | 750 | 130 | 20 | GO:0048729 |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 8.72e-08 | 59 | 130 | 7 | GO:0085029 | |
| GeneOntologyBiologicalProcess | muscle structure development | EFEMP2 LAMA1 DNER OBSCN LAMA5 LAMB1 LAMB2 LAMC1 NR4A1 NR3C1 KDM6B DLL1 JAG1 CSRP2 CNTNAP2 LRP2 LRP6 NOTCH1 MEGF10 MBNL3 NOTCH2 | 9.41e-08 | 858 | 130 | 21 | GO:0061061 |
| GeneOntologyBiologicalProcess | glial cell differentiation | RELN DNER LAMB2 GRN NR3C1 DLL1 LDLR CSPG5 CNTNAP2 LRP6 NOTCH1 NOTCH2 EPHA4 | 1.26e-07 | 321 | 130 | 13 | GO:0010001 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | NID2 EFEMP2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 NTN4 ITGBL1 FBLN2 CSPG5 JAG1 NOTCH1 | 3.25e-07 | 410 | 130 | 14 | GO:0031589 |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 3.60e-07 | 106 | 130 | 8 | GO:0051149 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | LAMA1 LAMA5 LAMC1 NR3C1 DLL1 ITGB5 PGR MST1 NTN4 EGF MEGF8 JAG1 LRP2 LRP6 NOTCH1 NOTCH2 EPHA4 | 3.65e-07 | 619 | 130 | 17 | GO:0002009 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 4.25e-07 | 74 | 130 | 7 | GO:0002011 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 4.80e-07 | 11 | 130 | 4 | GO:0110011 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | HSPG2 EFEMP2 LAMA1 LAMA5 NR4A3 GRN NR4A1 NR3C1 EPGN DLL1 LDLR PGR STAB1 MST1 EGF MEGF8 JAG1 LRP2 LRP6 NOTCH1 NOTCH2 NOTCH3 EPHA4 | 5.31e-07 | 1125 | 130 | 23 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | EFEMP2 LAMA1 LAMB1 LAMB2 LAMC1 NR3C1 DLL1 NOTCH1 MEGF10 NOTCH2 | 5.44e-07 | 199 | 130 | 10 | GO:0051147 |
| GeneOntologyBiologicalProcess | basement membrane assembly | 7.17e-07 | 12 | 130 | 4 | GO:0070831 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | HSPG2 LAMA5 LAMB1 LAMC1 NR4A3 GRN NR4A1 EPGN PGR MST1 EGF JAG1 LRP6 NOTCH1 NOTCH2 | 8.83e-07 | 514 | 130 | 15 | GO:0050678 |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | HSPG2 LAMB1 LAMC1 NR4A3 GRN NR4A1 EPGN MST1 EGF NOTCH1 NOTCH2 | 1.16e-06 | 270 | 130 | 11 | GO:0050679 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | EFEMP2 LAMA1 DNER OBSCN LAMB1 LAMB2 LAMC1 NR3C1 KDM6B DLL1 CSRP2 CNTNAP2 NOTCH1 MEGF10 NOTCH2 | 1.32e-06 | 531 | 130 | 15 | GO:0042692 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.44e-06 | 14 | 130 | 4 | GO:2001046 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.89e-06 | 92 | 130 | 7 | GO:0048844 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.95e-06 | 178 | 130 | 9 | GO:0022612 | |
| GeneOntologyBiologicalProcess | artery development | 2.03e-06 | 133 | 130 | 8 | GO:0060840 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | LAMA1 LAMA5 NR3C1 DLL1 PGR MST1 EGF MEGF8 LRP2 LRP6 NOTCH1 NOTCH2 EPHA4 | 2.67e-06 | 421 | 130 | 13 | GO:0060562 |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 3.09e-06 | 99 | 130 | 7 | GO:0045995 | |
| GeneOntologyBiologicalProcess | regeneration | 4.58e-06 | 252 | 130 | 10 | GO:0031099 | |
| GeneOntologyBiologicalProcess | response to axon injury | 4.58e-06 | 105 | 130 | 7 | GO:0048678 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 4.58e-06 | 105 | 130 | 7 | GO:0048708 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 4.83e-06 | 6 | 130 | 3 | GO:0071376 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 4.83e-06 | 6 | 130 | 3 | GO:0002085 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 4.83e-06 | 6 | 130 | 3 | GO:0043435 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 5.87e-06 | 109 | 130 | 7 | GO:0034446 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | HSPG2 LAMA5 LAMB1 LAMC1 NR4A3 GRN NR4A1 EPGN PGR MST1 EGF JAG1 LRP6 NOTCH1 NOTCH2 | 6.23e-06 | 603 | 130 | 15 | GO:0050673 |
| GeneOntologyBiologicalProcess | aorta development | 1.15e-05 | 80 | 130 | 6 | GO:0035904 | |
| GeneOntologyBiologicalProcess | muscle tissue development | HSPG2 EFEMP2 DNER NR4A1 NR3C1 KDM6B DLL1 CSRP2 CNTNAP2 LRP2 LRP6 NOTCH1 MEGF10 NOTCH2 | 1.18e-05 | 558 | 130 | 14 | GO:0060537 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.22e-05 | 23 | 130 | 4 | GO:2001044 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 1.23e-05 | 81 | 130 | 6 | GO:0031102 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.37e-05 | 124 | 130 | 7 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.52e-05 | 84 | 130 | 6 | GO:1903053 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | MKRN3 USP17L21 EPM2A USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 FBXO24 MEGF8 USP17L17 USP17L6P UNKL USP17L22 USP17L15 USP17L13 | 1.86e-05 | 1009 | 130 | 19 | GO:0070647 |
| GeneOntologyBiologicalProcess | tube development | HSPG2 EFEMP2 LAMA1 LAMA5 NR4A3 GRN NR4A1 NR3C1 EPGN DLL1 LDLR PGR STAB1 MST1 EGF MEGF8 JAG1 LRP2 LRP6 NOTCH1 NOTCH2 NOTCH3 EPHA4 | 2.07e-05 | 1402 | 130 | 23 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | HSPG2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 NR4A3 DLL1 FBLN2 CSPG5 JAG1 TMEM131L TNR NOTCH1 MEGF10 EPHA4 | 2.10e-05 | 927 | 130 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of cell migration | SELL SEMA4F RELN LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 NR4A3 GRN F7 F10 PGR MST1 FBN2 EGF FURIN JAG1 TNR NOTCH1 EPHA4 | 2.21e-05 | 1211 | 130 | 21 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of locomotion | SELL SEMA4F RELN LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 NR4A3 GRN F7 F10 PGR MST1 FBN2 EGF MEGF8 FURIN JAG1 TNR NOTCH1 EPHA4 | 2.74e-05 | 1327 | 130 | 22 | GO:0040012 |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 2.84e-05 | 10 | 130 | 3 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 2.84e-05 | 10 | 130 | 3 | GO:0072015 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | MKRN3 USP17L21 EPM2A USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 FBXO24 MEGF8 USP17L17 USP17L6P UNKL USP17L22 USP17L15 USP17L13 | 4.36e-05 | 1074 | 130 | 19 | GO:0043687 |
| GeneOntologyBiologicalProcess | regulation of cell motility | SELL SEMA4F RELN LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 NR4A3 GRN F7 F10 PGR MST1 FBN2 EGF FURIN JAG1 TNR NOTCH1 EPHA4 | 4.98e-05 | 1280 | 130 | 21 | GO:2000145 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | HSPG2 IL13RA1 LAMB1 LAMC1 NR4A3 GRN NR4A1 EPGN DLL1 PGR CNBP MST1 EGF LRP2 LRP6 NOTCH1 MEGF10 NOTCH2 NOTCH3 EPHA4 | 5.51e-05 | 1190 | 130 | 20 | GO:0008284 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | HSPG2 EFEMP2 LAMA1 GRN NR4A1 EPGN DLL1 LDLR STAB1 EGF MEGF8 JAG1 LRP2 NOTCH1 NOTCH2 NOTCH3 | 5.68e-05 | 817 | 130 | 16 | GO:0048514 |
| GeneOntologyBiologicalProcess | central nervous system development | HSPG2 RELN NR4A2 LAMB1 LAMB2 NR4A3 GRN NR3C1 KDM6B DLL1 LDLR EGF CHD5 CNTNAP2 LRP2 LRP6 TNR NOTCH1 NOTCH3 EPHA4 | 5.98e-05 | 1197 | 130 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of protein tyrosine kinase activity | 6.78e-05 | 35 | 130 | 4 | GO:0061098 | |
| GeneOntologyBiologicalProcess | response to wounding | MATN2 LAMB2 GRN MATN4 F7 ITGB5 F10 SCUBE1 PROZ CSPG5 TNR NOTCH2 PROC EPHA4 | 7.25e-05 | 659 | 130 | 14 | GO:0009611 |
| GeneOntologyBiologicalProcess | axon regeneration | 7.49e-05 | 69 | 130 | 5 | GO:0031103 | |
| GeneOntologyBiologicalProcess | blood vessel development | HSPG2 EFEMP2 LAMA1 GRN NR4A1 EPGN DLL1 LDLR STAB1 EGF MEGF8 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 NOTCH3 | 7.58e-05 | 929 | 130 | 17 | GO:0001568 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 7.62e-05 | 162 | 130 | 7 | GO:0072073 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 8.46e-05 | 14 | 130 | 3 | GO:0070986 | |
| GeneOntologyBiologicalProcess | circulatory system development | HSPG2 EFEMP2 LAMA1 GRN NR4A1 NR3C1 EPGN KDM6B BCOR DLL1 LDLR STAB1 SCUBE1 EGF MEGF8 JAG1 LRP2 LRP6 LTBP1 NOTCH1 NOTCH2 NOTCH3 | 9.45e-05 | 1442 | 130 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 1.05e-04 | 15 | 130 | 3 | GO:0048505 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.18e-04 | 3 | 130 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 1.18e-04 | 3 | 130 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | nephron development | 1.19e-04 | 174 | 130 | 7 | GO:0072006 | |
| GeneOntologyBiologicalProcess | epithelium development | LAMA1 LAMA5 LAMB2 LAMC1 NR3C1 KDM6B DLL1 SLC40A1 ITGB5 PGR MST1 NTN4 SCUBE1 EGF MEGF8 JAG1 LRP2 LRP6 NOTCH1 NOTCH2 PROC EPHA4 | 1.24e-04 | 1469 | 130 | 22 | GO:0060429 |
| GeneOntologyBiologicalProcess | vasculature development | HSPG2 EFEMP2 LAMA1 GRN NR4A1 EPGN DLL1 LDLR STAB1 EGF MEGF8 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 NOTCH3 | 1.26e-04 | 969 | 130 | 17 | GO:0001944 |
| GeneOntologyBiologicalProcess | glomerulus development | 1.26e-04 | 77 | 130 | 5 | GO:0032835 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 1.43e-04 | 79 | 130 | 5 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 1.52e-04 | 80 | 130 | 5 | GO:0003143 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 1.56e-04 | 17 | 130 | 3 | GO:0040034 | |
| GeneOntologyBiologicalProcess | endothelium development | 1.57e-04 | 182 | 130 | 7 | GO:0003158 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF585A NR4A2 NR4A3 NR4A1 NR3C1 KDM6B DLL1 SLC40A1 PGR ZNF585B RLF CNBP JAG1 LRP6 MLLT6 NR3C2 PRDM15 NR1I3 NOTCH1 NOTCH2 NOTCH3 | 1.59e-04 | 1390 | 130 | 21 | GO:0045944 |
| GeneOntologyBiologicalProcess | nephron epithelium development | 1.62e-04 | 128 | 130 | 6 | GO:0072009 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 1.84e-04 | 45 | 130 | 4 | GO:0060603 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.07e-04 | 134 | 130 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | astrocyte development | 2.18e-04 | 47 | 130 | 4 | GO:0014002 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 2.18e-04 | 47 | 130 | 4 | GO:0035850 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 2.35e-04 | 4 | 130 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | muscle cell development | 2.41e-04 | 259 | 130 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | SELL SEMA4F RELN LAMB1 NR4A3 GRN F7 F10 PGR EGF MEGF8 FURIN NOTCH1 EPHA4 | 2.49e-04 | 742 | 130 | 14 | GO:0040017 |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 2.50e-04 | 89 | 130 | 5 | GO:0060411 | |
| GeneOntologyBiologicalProcess | embryo development | HSPG2 LAMA1 LAMA3 LAMA5 NR4A3 GRN KDM6B BCOR DLL1 LRP1B FBN2 MEGF8 FURIN JAG1 CNTNAP2 LRP2 LRP6 USP17L15 NOTCH1 NOTCH2 USP17L13 | 2.51e-04 | 1437 | 130 | 21 | GO:0009790 |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.58e-04 | 20 | 130 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | forebrain development | RELN NR4A2 LAMB1 NR4A3 KDM6B CHD5 LRP2 LRP6 TNR NOTCH1 NOTCH3 | 2.74e-04 | 489 | 130 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.97e-04 | 338 | 130 | 9 | GO:0045165 | |
| GeneOntologyBiologicalProcess | brain development | HSPG2 RELN NR4A2 LAMB1 NR4A3 KDM6B DLL1 EGF CHD5 CNTNAP2 LRP2 LRP6 TNR NOTCH1 NOTCH3 | 3.40e-04 | 859 | 130 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | podocyte differentiation | 3.45e-04 | 22 | 130 | 3 | GO:0072112 | |
| GeneOntologyCellularComponent | laminin complex | 9.66e-17 | 10 | 133 | 8 | GO:0043256 | |
| GeneOntologyCellularComponent | extracellular matrix | NID2 HSPG2 RELN ZAN MATN2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 MUC5B SSPOP F7 MST1 NTN4 FBLN2 FBN2 MEGF6 MEGF9 ADAMTS20 LTBP1 LTBP2 TNR LTBP4 MUC5AC | 1.05e-16 | 656 | 133 | 29 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NID2 HSPG2 RELN ZAN MATN2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 MUC5B SSPOP F7 MST1 NTN4 FBLN2 FBN2 MEGF6 MEGF9 ADAMTS20 LTBP1 LTBP2 TNR LTBP4 MUC5AC | 1.14e-16 | 658 | 133 | 29 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NID2 HSPG2 RELN MATN2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 SSPOP F7 MST1 NTN4 FBLN2 FBN2 MEGF6 MEGF9 ADAMTS20 LTBP1 LTBP2 TNR LTBP4 | 4.22e-16 | 530 | 133 | 26 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | NID2 HSPG2 MATN2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NTN4 MEGF9 | 9.40e-13 | 122 | 133 | 13 | GO:0005604 |
| GeneOntologyCellularComponent | Golgi lumen | 3.24e-08 | 109 | 133 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 5.63e-08 | 17 | 133 | 5 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 9.33e-08 | 59 | 133 | 7 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin-10 complex | 2.52e-07 | 3 | 133 | 3 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 2.52e-07 | 3 | 133 | 3 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-1 complex | 2.52e-07 | 3 | 133 | 3 | GO:0005606 | |
| GeneOntologyCellularComponent | laminin-3 complex | 2.52e-07 | 3 | 133 | 3 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.00e-06 | 4 | 133 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | microfibril | 1.07e-06 | 13 | 133 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 EPM2A USP17L12 COPA USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CSPG5 FURIN USP17L6P NR3C2 USP17L22 USP17L15 NOTCH1 SEC23B NOTCH2 NOTCH3 USP17L13 | 2.17e-05 | 1293 | 133 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 EPM2A USP17L12 COPA USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CSPG5 FURIN USP17L6P NR3C2 USP17L22 USP17L15 NOTCH1 SEC23B NOTCH2 NOTCH3 USP17L13 | 2.33e-05 | 1299 | 133 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | cell surface | SELL NID2 IL13RA1 LDLR ITGB5 F10 CD163 ITGBL1 SCUBE1 CSPG5 FURIN CNTNAP2 LRP2 LRP6 ASTN1 TNR NOTCH1 NOTCH2 NOTCH3 EPHA4 | 2.43e-05 | 1111 | 133 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 EPM2A USP17L12 COPA USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CSPG5 FURIN USP17L6P NR3C2 USP17L22 USP17L15 NOTCH1 SEC23B NOTCH2 NOTCH3 USP17L13 | 3.22e-05 | 1327 | 133 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.36e-05 | 332 | 133 | 10 | GO:0005788 | |
| GeneOntologyCellularComponent | neuromuscular junction | 8.16e-05 | 112 | 133 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 1.20e-04 | 3 | 133 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | CHD-type complex | 1.60e-04 | 17 | 133 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 1.60e-04 | 17 | 133 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | matrilin complex | 2.39e-04 | 4 | 133 | 2 | GO:0120216 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.60e-04 | 215 | 133 | 7 | GO:0030662 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 4.62e-04 | 24 | 133 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | perikaryon | 5.71e-04 | 223 | 133 | 7 | GO:0043204 | |
| GeneOntologyCellularComponent | cerebellar granule cell to Purkinje cell synapse | 8.26e-04 | 7 | 133 | 2 | GO:0150048 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.19e-03 | 33 | 133 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | receptor complex | IL13RA1 STXBP5 LRP1B LDLR ITGB5 ITGBL1 LRP2 NR3C2 NOTCH1 NOTCH2 NOTCH3 | 1.23e-03 | 581 | 133 | 11 | GO:0043235 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.63e-03 | 79 | 133 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.91e-03 | 523 | 133 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SEMA4F NTNG1 LAMA5 GRN CHD4 NR3C1 ITGB5 CSPG5 CNTNAP2 NR3C2 TNR NOTCH1 EPHA4 | 2.15e-03 | 817 | 133 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | coated vesicle | 2.17e-03 | 360 | 133 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.39e-03 | 212 | 133 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 2.51e-03 | 147 | 133 | 5 | GO:0030665 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.99e-03 | 13 | 133 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.15e-03 | 155 | 133 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SELL COPA STXBP5 EPGN LDLR CD163 STAB1 MALRD1 EGF CSPG5 FURIN OSBPL9 LRP2 LRP6 NOTCH1 SEC23B EPHA4 | 3.89e-03 | 1307 | 133 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.97e-03 | 101 | 133 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 4.14e-03 | 237 | 133 | 6 | GO:0030136 | |
| GeneOntologyCellularComponent | vesicle membrane | SELL COPA STXBP5 EPGN LDLR CD163 STAB1 MALRD1 EGF CSPG5 FURIN OSBPL9 LRP2 LRP6 NOTCH1 SEC23B EPHA4 | 4.46e-03 | 1325 | 133 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 6.93e-03 | 61 | 133 | 3 | GO:0030660 | |
| HumanPheno | Peripheral pulmonary artery stenosis | 2.78e-06 | 40 | 53 | 6 | HP:0004969 | |
| HumanPheno | Multiple bladder diverticula | 1.05e-05 | 5 | 53 | 3 | HP:0012619 | |
| MousePheno | abnormal apoptosis | EPM2A EFEMP2 LAMA1 NR4A2 LAMA5 CRELD2 LAMB2 NR4A3 GRN MUC5B CHD4 NR4A1 NR3C1 LDLR SLC40A1 LECT2 CNBP FBXO24 FBN2 LRP2 ASTN1 USP17L15 NOTCH1 MEGF10 SEC23B NOTCH2 USP17L13 | 8.82e-07 | 1353 | 102 | 27 | MP:0001648 |
| MousePheno | abnormal programmed cell death | EPM2A EFEMP2 LAMA1 NR4A2 LAMA5 CRELD2 LAMB2 NR4A3 GRN MUC5B CHD4 NR4A1 NR3C1 LDLR SLC40A1 LECT2 CNBP FBXO24 FBN2 LRP2 ASTN1 USP17L15 NOTCH1 MEGF10 SEC23B NOTCH2 USP17L13 | 9.76e-07 | 1360 | 102 | 27 | MP:0014355 |
| MousePheno | abnormal nervous system development | HSPG2 RELN DNER NR4A2 LAMA5 LAMC1 NR4A3 E2F5 BCOR DLL1 SLC40A1 CNBP SCUBE1 MEGF8 FURIN JAG1 LRP2 ADAMTS20 LRP6 ASTN1 LTBP1 PRDM15 NOTCH1 NOTCH3 EPHA4 | 2.67e-06 | 1257 | 102 | 25 | MP:0003861 |
| MousePheno | increased apoptosis | EPM2A LAMA1 NR4A2 LAMA5 CRELD2 LAMB2 NR4A3 GRN MUC5B CHD4 LDLR SLC40A1 LECT2 FBXO24 LRP2 ASTN1 USP17L15 NOTCH1 MEGF10 SEC23B NOTCH2 USP17L13 | 2.74e-06 | 1008 | 102 | 22 | MP:0006042 |
| MousePheno | increased cell death | EPM2A LAMA1 NR4A2 LAMA5 CRELD2 LAMB2 NR4A3 GRN MUC5B CHD4 LDLR SLC40A1 LECT2 FBXO24 LRP2 ASTN1 USP17L15 NOTCH1 MEGF10 SEC23B NOTCH2 USP17L13 | 3.28e-06 | 1019 | 102 | 22 | MP:0012556 |
| MousePheno | abnormal brain development | RELN DNER NR4A2 LAMA5 LAMC1 NR4A3 E2F5 BCOR DLL1 SLC40A1 SCUBE1 LRP2 ADAMTS20 LRP6 ASTN1 PRDM15 NOTCH3 | 3.34e-06 | 638 | 102 | 17 | MP:0000913 |
| MousePheno | decreased circulating unsaturated transferrin level | 2.06e-05 | 8 | 102 | 3 | MP:0011897 | |
| MousePheno | decreased circulating transferrin level | 4.36e-05 | 10 | 102 | 3 | MP:0011894 | |
| MousePheno | absent neurocranium | 5.96e-05 | 11 | 102 | 3 | MP:0000075 | |
| MousePheno | abnormal forebrain morphology | HSPG2 RELN EPM2A NR4A2 LAMC1 NR4A3 GRN E2F5 BCOR SSPOP LDLR SLC40A1 CNBP SCUBE1 CNTNAP2 LRP2 LRP6 TNR PRDM15 EPHA4 | 8.06e-05 | 1072 | 102 | 20 | MP:0000783 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | EFEMP2 NR4A2 LAMA3 LAMA5 LAMB2 LAMB3 LAMC1 CHD4 NR3C1 KDM6B DLL1 F10 SCUBE1 MEGF8 LRP2 LRP6 NR3C2 LTBP1 SYT13 SEC23B NOTCH2 PROC | 9.92e-05 | 1269 | 102 | 22 | MP:0011111 |
| MousePheno | aneurysm | 1.18e-04 | 35 | 102 | 4 | MP:0003279 | |
| MousePheno | abnormal ascending aorta and coronary artery attachment | 1.57e-04 | 3 | 102 | 2 | MP:0010472 | |
| MousePheno | abnormal motor coordination/balance | RELN EPM2A STXBP5L DNER NR4A2 LAMB1 NR4A3 GRN E2F5 EPGN JAG1 CNTNAP2 LRP2 ASTN1 IGLON5 NOTCH3 EPHA4 | 1.80e-04 | 873 | 102 | 17 | MP:0001516 |
| MousePheno | neonatal lethality | EFEMP2 NR4A2 LAMB3 LAMC1 CHD4 NR3C1 KDM6B F7 F10 CNBP SCUBE1 LRP6 LTBP1 SEC23B NOTCH2 PROC | 2.08e-04 | 799 | 102 | 16 | MP:0002058 |
| MousePheno | abnormal forebrain development | 2.38e-04 | 225 | 102 | 8 | MP:0003232 | |
| MousePheno | abnormal aorta morphology | 2.38e-04 | 225 | 102 | 8 | MP:0000272 | |
| MousePheno | increased inflammatory response | SELL NID2 HSPG2 COPA LAMA3 LAMB2 GRN MUC5B NR4A1 LDLR LECT2 CD163 PGR MST1 LRP6 LTBP4 NOTCH1 SEC23B PROC | 2.58e-04 | 1077 | 102 | 19 | MP:0001846 |
| MousePheno | exencephaly | 2.76e-04 | 230 | 102 | 8 | MP:0000914 | |
| MousePheno | abnormal brain thrombosis | 3.13e-04 | 4 | 102 | 2 | MP:0031168 | |
| MousePheno | abnormal hepatobiliary system physiology | CRELD2 GRN NR3C1 LDLR SLC40A1 LECT2 MALRD1 JAG1 LRP6 NOTCH1 PROC | 3.13e-04 | 433 | 102 | 11 | MP:0002139 |
| MousePheno | abnormal neural tube morphology | LAMA5 LAMC1 DLL1 SLC40A1 CNBP SCUBE1 FURIN JAG1 LRP2 LRP6 LTBP1 PRDM15 NOTCH1 | 3.57e-04 | 591 | 102 | 13 | MP:0002151 |
| MousePheno | abnormal artery morphology | HSPG2 EFEMP2 LAMA5 DLL1 LDLR MEGF8 LRP2 LTBP1 LTBP4 NOTCH1 NOTCH3 | 3.59e-04 | 440 | 102 | 11 | MP:0002191 |
| MousePheno | abnormal muscle morphology | HSPG2 EPM2A EFEMP2 OBSCN LAMC1 CHD4 DLL1 CD163 PGR FBN2 MEGF8 CSRP2 LRP2 LTBP1 LTBP4 NOTCH1 MBNL3 NOTCH2 NOTCH3 | 3.61e-04 | 1106 | 102 | 19 | MP:0002108 |
| MousePheno | abnormal blood coagulation | 3.68e-04 | 240 | 102 | 8 | MP:0002551 | |
| MousePheno | abnormal forelimb morphology | 3.69e-04 | 182 | 102 | 7 | MP:0000550 | |
| MousePheno | abnormal hemostasis | 3.89e-04 | 242 | 102 | 8 | MP:0009676 | |
| MousePheno | abnormal circulating unsaturated transferrin level | 3.93e-04 | 20 | 102 | 3 | MP:0011895 | |
| MousePheno | abnormal thoracic aorta morphology | 4.40e-04 | 134 | 102 | 6 | MP:0010468 | |
| MousePheno | perinatal lethality | HSPG2 EFEMP2 NR4A2 LAMB3 LAMC1 CHD4 NR3C1 KDM6B DLL1 F7 F10 CNBP SCUBE1 LRP2 LRP6 LTBP1 SEC23B NOTCH2 PROC | 4.72e-04 | 1130 | 102 | 19 | MP:0002081 |
| MousePheno | increased heart iron level | 5.20e-04 | 5 | 102 | 2 | MP:0020367 | |
| MousePheno | kidney microaneurysm | 5.20e-04 | 5 | 102 | 2 | MP:0010451 | |
| MousePheno | abnormal circulating transferrin level | 5.25e-04 | 22 | 102 | 3 | MP:0011892 | |
| MousePheno | abnormal ascending aorta morphology | 5.25e-04 | 22 | 102 | 3 | MP:0009867 | |
| MousePheno | abnormal skeletal muscle fiber size | 5.55e-04 | 140 | 102 | 6 | MP:0009398 | |
| MousePheno | increased cell proliferation | 6.22e-04 | 396 | 102 | 10 | MP:0000351 | |
| MousePheno | perinatal lethality, complete penetrance | EFEMP2 NR4A2 LAMB3 LAMC1 NR3C1 KDM6B DLL1 SCUBE1 LRP2 LRP6 LTBP1 SEC23B NOTCH2 PROC | 6.44e-04 | 712 | 102 | 14 | MP:0011089 |
| MousePheno | abnormal skin morphology | RELN STXBP5L EFEMP2 LAMA3 LAMA5 LAMB3 GRN MUC5B DLL1 LDLR SLC40A1 ITGB5 FBN2 MEGF8 CHD5 JAG1 ADAMTS20 LRP6 MLLT6 LTBP4 IGLON5 NOTCH2 | 6.85e-04 | 1455 | 102 | 22 | MP:0002060 |
| MousePheno | abnormal liver physiology | 6.86e-04 | 401 | 102 | 10 | MP:0000609 | |
| Domain | EGF_2 | SELL NID2 HSPG2 RELN ZAN MATN2 EFEMP2 LAMA1 DNER LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 EPGN VWCE DLL1 SSPOP LRP1B F7 LDLR ITGB5 F10 STAB1 ITGBL1 SCUBE1 FBLN2 FBN2 PROZ MALRD1 EGF MEGF6 MEGF8 MEGF9 CSPG5 JAG1 CNTNAP2 LRP2 LRP6 ASTN1 LTBP1 LTBP2 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 PROC | 3.33e-64 | 265 | 131 | 53 | PS01186 |
| Domain | EGF | SELL NID2 HSPG2 RELN ZAN MATN2 EFEMP2 LAMA1 DNER LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMC1 MATN4 EPGN VWCE DLL1 LRP1B F7 LDLR ITGB5 F10 STAB1 ITGBL1 SCUBE1 FBLN2 FBN2 PROZ MALRD1 EGF MEGF6 MEGF8 MEGF9 CSPG5 JAG1 CNTNAP2 LRP2 LRP6 ASTN1 LTBP1 LTBP2 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 PROC | 1.30e-63 | 235 | 131 | 51 | SM00181 |
| Domain | EGF_1 | SELL HSPG2 RELN ZAN EFEMP2 LAMA1 DNER LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 EPGN VWCE DLL1 SSPOP LRP1B F7 LDLR ITGB5 F10 STAB1 NTN4 ITGBL1 SCUBE1 FBLN2 FBN2 PROZ MALRD1 EGF MEGF6 MEGF8 MEGF9 CSPG5 JAG1 CNTNAP2 LRP2 LRP6 ASTN1 LTBP1 LTBP2 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 PROC | 2.16e-63 | 255 | 131 | 52 | PS00022 |
| Domain | EGF-like_CS | SELL NID2 HSPG2 RELN ZAN MATN2 EFEMP2 LAMA1 DNER LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 EPGN VWCE DLL1 LRP1B F7 LDLR ITGB5 F10 STAB1 NTN4 SCUBE1 FBLN2 FBN2 PROZ MALRD1 EGF MEGF6 MEGF8 MEGF9 CSPG5 JAG1 CNTNAP2 LRP2 LRP6 ASTN1 LTBP1 LTBP2 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 PROC | 8.12e-63 | 261 | 131 | 52 | IPR013032 |
| Domain | EGF-like_dom | SELL NID2 HSPG2 RELN ZAN MATN2 EFEMP2 LAMA1 DNER LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMC1 MATN4 EPGN VWCE DLL1 LRP1B F7 LDLR F10 STAB1 ITGBL1 SCUBE1 FBLN2 FBN2 PROZ MALRD1 EGF MEGF6 MEGF8 MEGF9 CSPG5 JAG1 CNTNAP2 LRP2 LRP6 ASTN1 LTBP1 LTBP2 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 PROC | 1.95e-60 | 249 | 131 | 50 | IPR000742 |
| Domain | EGF_3 | SELL NID2 HSPG2 RELN ZAN MATN2 EFEMP2 DNER NTNG1 CRELD2 MATN4 EPGN VWCE DLL1 SSPOP LRP1B F7 LDLR F10 STAB1 SCUBE1 FBLN2 FBN2 PROZ MALRD1 EGF MEGF6 MEGF8 CSPG5 JAG1 CNTNAP2 LRP2 LRP6 ASTN1 LTBP1 LTBP2 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 PROC | 1.05e-49 | 235 | 131 | 43 | PS50026 |
| Domain | Growth_fac_rcpt_ | NID2 HSPG2 MATN2 EFEMP2 LAMA1 DNER LAMA3 LAMA5 CRELD2 LAMB1 LAMB2 LAMC1 MATN4 VWCE DLL1 LRP1B LDLR STAB1 NTN4 SCUBE1 FBLN2 FBN2 EGF MEGF6 MEGF8 FURIN JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 7.46e-42 | 156 | 131 | 34 | IPR009030 |
| Domain | EGF_CA | NID2 HSPG2 MATN2 EFEMP2 DNER CRELD2 MATN4 VWCE DLL1 LRP1B F7 LDLR F10 STAB1 SCUBE1 FBLN2 FBN2 PROZ EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 PROC | 1.23e-38 | 122 | 131 | 30 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NID2 HSPG2 MATN2 EFEMP2 DNER CRELD2 MATN4 VWCE DLL1 LRP1B F7 LDLR F10 STAB1 SCUBE1 FBLN2 FBN2 PROZ EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 PROC | 2.13e-38 | 124 | 131 | 30 | IPR001881 |
| Domain | ASX_HYDROXYL | NID2 MATN2 EFEMP2 DNER CRELD2 MATN4 VWCE DLL1 LRP1B F7 LDLR F10 SCUBE1 FBLN2 FBN2 PROZ EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 PROC | 7.51e-38 | 100 | 131 | 28 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NID2 MATN2 EFEMP2 DNER CRELD2 MATN4 VWCE DLL1 LRP1B F7 LDLR F10 SCUBE1 FBLN2 FBN2 PROZ EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 PROC | 4.83e-37 | 106 | 131 | 28 | IPR000152 |
| Domain | EGF | SELL NID2 HSPG2 ZAN MATN2 DNER MATN4 EPGN DLL1 LRP1B F7 ITGB5 F10 STAB1 PROZ MALRD1 EGF MEGF6 JAG1 CNTNAP2 LRP2 LRP6 LTBP1 LTBP2 NOTCH1 NOTCH2 NOTCH3 PROC | 1.08e-34 | 126 | 131 | 28 | PF00008 |
| Domain | EGF_Ca-bd_CS | NID2 EFEMP2 DNER CRELD2 VWCE DLL1 LRP1B F7 LDLR F10 SCUBE1 FBLN2 FBN2 EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 PROC | 8.45e-33 | 97 | 131 | 25 | IPR018097 |
| Domain | EGF_CA | NID2 EFEMP2 DNER CRELD2 VWCE DLL1 LRP1B F7 LDLR F10 SCUBE1 FBLN2 FBN2 EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 PROC | 1.50e-32 | 99 | 131 | 25 | PS01187 |
| Domain | EGF_CA | NID2 MATN2 EFEMP2 CRELD2 MATN4 VWCE LRP1B LDLR SCUBE1 FBLN2 FBN2 EGF MEGF6 MEGF8 JAG1 LRP2 LTBP1 LTBP2 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 7.57e-29 | 86 | 131 | 22 | PF07645 |
| Domain | Laminin_EGF | HSPG2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 STAB1 NTN4 MEGF6 MEGF8 MEGF9 MEGF10 | 2.60e-25 | 38 | 131 | 16 | IPR002049 |
| Domain | Laminin_EGF | HSPG2 LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 STAB1 NTN4 MEGF6 MEGF8 MEGF9 MEGF10 | 6.18e-24 | 35 | 131 | 15 | PF00053 |
| Domain | EGF_Lam | HSPG2 LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 STAB1 NTN4 MEGF6 MEGF8 MEGF9 MEGF10 | 6.18e-24 | 35 | 131 | 15 | SM00180 |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 5.58e-21 | 16 | 131 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 5.58e-21 | 16 | 131 | 11 | IPR006861 |
| Domain | EGF_LAM_2 | HSPG2 LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 STAB1 NTN4 MEGF8 MEGF9 | 5.85e-21 | 30 | 131 | 13 | PS50027 |
| Domain | EGF_LAM_1 | HSPG2 LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 STAB1 NTN4 MEGF8 MEGF9 | 5.85e-21 | 30 | 131 | 13 | PS01248 |
| Domain | EGF_extracell | RELN DNER LRP1B ITGB5 STAB1 ITGBL1 MEGF6 JAG1 LRP2 LTBP2 TNR NOTCH1 MEGF10 NOTCH3 | 4.52e-18 | 60 | 131 | 14 | IPR013111 |
| Domain | EGF_2 | RELN DNER LRP1B ITGB5 STAB1 ITGBL1 MEGF6 JAG1 LRP2 LTBP2 TNR NOTCH1 MEGF10 NOTCH3 | 4.52e-18 | 60 | 131 | 14 | PF07974 |
| Domain | Laminin_N | 3.41e-16 | 16 | 131 | 9 | IPR008211 | |
| Domain | LAMININ_NTER | 3.41e-16 | 16 | 131 | 9 | PS51117 | |
| Domain | Laminin_N | 3.41e-16 | 16 | 131 | 9 | PF00055 | |
| Domain | LamNT | 3.41e-16 | 16 | 131 | 9 | SM00136 | |
| Domain | cEGF | 9.82e-16 | 26 | 131 | 10 | IPR026823 | |
| Domain | cEGF | 9.82e-16 | 26 | 131 | 10 | PF12662 | |
| Domain | USP_CS | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 3.03e-14 | 66 | 131 | 12 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 6.39e-14 | 70 | 131 | 12 | PS00972 |
| Domain | UCH | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 7.65e-14 | 71 | 131 | 12 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 7.65e-14 | 71 | 131 | 12 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 9.12e-14 | 72 | 131 | 12 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 9.12e-14 | 72 | 131 | 12 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 9.12e-14 | 72 | 131 | 12 | IPR001394 |
| Domain | hEGF | 1.92e-13 | 28 | 131 | 9 | PF12661 | |
| Domain | Galactose-bd-like | LAMA1 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 SSPOP NTN4 FURIN CNTNAP2 EPHA4 | 2.49e-12 | 94 | 131 | 12 | IPR008979 |
| Domain | Ldl_recept_b | 3.04e-10 | 14 | 131 | 6 | PF00058 | |
| Domain | LDLRB | 3.04e-10 | 14 | 131 | 6 | PS51120 | |
| Domain | LY | 5.04e-10 | 15 | 131 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.04e-10 | 15 | 131 | 6 | IPR000033 | |
| Domain | LAMININ_IVA | 8.66e-10 | 8 | 131 | 5 | PS51115 | |
| Domain | Laminin_B | 8.66e-10 | 8 | 131 | 5 | PF00052 | |
| Domain | LamB | 8.66e-10 | 8 | 131 | 5 | SM00281 | |
| Domain | Laminin_IV | 8.66e-10 | 8 | 131 | 5 | IPR000034 | |
| Domain | VWC_out | 2.67e-09 | 19 | 131 | 6 | SM00215 | |
| Domain | LDLR_class-A_CS | 1.09e-08 | 40 | 131 | 7 | IPR023415 | |
| Domain | Pept_S1A_FX | 1.15e-08 | 5 | 131 | 4 | IPR012224 | |
| Domain | Ldl_recept_a | 2.58e-08 | 45 | 131 | 7 | PF00057 | |
| Domain | TIL_dom | 2.99e-08 | 14 | 131 | 5 | IPR002919 | |
| Domain | zf-C4 | 3.03e-08 | 46 | 131 | 7 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 3.03e-08 | 46 | 131 | 7 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 3.03e-08 | 46 | 131 | 7 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 3.03e-08 | 46 | 131 | 7 | PS00031 | |
| Domain | ZnF_C4 | 3.03e-08 | 46 | 131 | 7 | SM00399 | |
| Domain | - | 3.03e-08 | 46 | 131 | 7 | 4.10.400.10 | |
| Domain | - | 3.54e-08 | 47 | 131 | 7 | 1.10.565.10 | |
| Domain | LDLRA_1 | 4.12e-08 | 48 | 131 | 7 | PS01209 | |
| Domain | HOLI | 4.12e-08 | 48 | 131 | 7 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 4.12e-08 | 48 | 131 | 7 | IPR000536 | |
| Domain | Hormone_recep | 4.12e-08 | 48 | 131 | 7 | PF00104 | |
| Domain | LDLRA_2 | 4.78e-08 | 49 | 131 | 7 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 4.78e-08 | 49 | 131 | 7 | IPR002172 | |
| Domain | LDLa | 4.78e-08 | 49 | 131 | 7 | SM00192 | |
| Domain | TB | 7.96e-08 | 7 | 131 | 4 | PF00683 | |
| Domain | - | 1.40e-07 | 57 | 131 | 7 | 3.30.50.10 | |
| Domain | - | 1.58e-07 | 8 | 131 | 4 | 3.90.290.10 | |
| Domain | Znf_NHR/GATA | 1.59e-07 | 58 | 131 | 7 | IPR013088 | |
| Domain | VWC | 2.44e-07 | 38 | 131 | 6 | SM00214 | |
| Domain | TB | 2.83e-07 | 9 | 131 | 4 | PS51364 | |
| Domain | TB_dom | 2.83e-07 | 9 | 131 | 4 | IPR017878 | |
| Domain | - | 2.86e-07 | 39 | 131 | 6 | 2.120.10.30 | |
| Domain | DUF3454 | 3.37e-07 | 3 | 131 | 3 | PF11936 | |
| Domain | CHDCT2 | 3.37e-07 | 3 | 131 | 3 | PF08074 | |
| Domain | CHDNT | 3.37e-07 | 3 | 131 | 3 | PF08073 | |
| Domain | DUF1086 | 3.37e-07 | 3 | 131 | 3 | IPR009462 | |
| Domain | DUF1087 | 3.37e-07 | 3 | 131 | 3 | IPR009463 | |
| Domain | DUF3454_notch | 3.37e-07 | 3 | 131 | 3 | IPR024600 | |
| Domain | CHD_N | 3.37e-07 | 3 | 131 | 3 | IPR012958 | |
| Domain | CHD_C2 | 3.37e-07 | 3 | 131 | 3 | IPR012957 | |
| Domain | Nuc_orph_rcpt | 3.37e-07 | 3 | 131 | 3 | IPR003070 | |
| Domain | DUF1087 | 3.37e-07 | 3 | 131 | 3 | PF06465 | |
| Domain | DUF1086 | 3.37e-07 | 3 | 131 | 3 | PF06461 | |
| Domain | DUF1087 | 3.37e-07 | 3 | 131 | 3 | SM01147 | |
| Domain | DUF1086 | 3.37e-07 | 3 | 131 | 3 | SM01146 | |
| Domain | DUF3454 | 3.37e-07 | 3 | 131 | 3 | SM01334 | |
| Domain | VWF_dom | 4.53e-07 | 42 | 131 | 6 | IPR001007 | |
| Domain | Nuclear_hrmn_rcpt | 7.90e-07 | 46 | 131 | 6 | IPR001723 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.90e-07 | 46 | 131 | 6 | IPR011042 | |
| Domain | EGF_3 | 1.10e-06 | 12 | 131 | 4 | PF12947 | |
| Domain | TIL | 1.10e-06 | 12 | 131 | 4 | PF01826 | |
| Domain | EGF_dom | 1.10e-06 | 12 | 131 | 4 | IPR024731 | |
| Domain | - | 1.10e-06 | 12 | 131 | 4 | 4.10.740.10 | |
| Domain | Coagulation_fac_subgr_Gla_dom | 1.10e-06 | 12 | 131 | 4 | IPR017857 | |
| Domain | C8 | 1.10e-06 | 12 | 131 | 4 | PF08742 | |
| Domain | Notch | 1.34e-06 | 4 | 131 | 3 | IPR008297 | |
| Domain | NODP | 1.34e-06 | 4 | 131 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 1.34e-06 | 4 | 131 | 3 | IPR011656 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.14e-17 | 45 | 110 | 13 | MM15671 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 HSPG2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 ITGB5 NTN4 SCUBE1 FBLN2 FBN2 FURIN LTBP1 LTBP2 TNR LTBP4 | 1.31e-14 | 300 | 110 | 21 | M610 |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.67e-13 | 11 | 110 | 7 | M158 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.60e-13 | 30 | 110 | 9 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.52e-11 | 59 | 110 | 10 | M27218 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | HSPG2 RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 TNR | 4.53e-11 | 84 | 110 | 11 | M7098 |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 6.66e-11 | 46 | 110 | 9 | M239 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.43e-10 | 76 | 110 | 10 | M27219 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.49e-09 | 44 | 110 | 8 | M26969 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.55e-09 | 30 | 110 | 7 | M27772 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.90e-09 | 191 | 110 | 13 | MM15289 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L12 COPA USP17L20 USP17L11 USP17L24 NR4A2 NTNG1 LAMB1 LAMB2 USP17L5 LAMC1 USP17L10 MUC5B CHD3 USP17L19 NR3C1 SSPOP F7 F10 PGR USP17L18 PROZ USP17L17 FURIN LYPD5 ADAMTS20 NR3C2 LTBP1 USP17L22 MUC5AC USP17L15 PROC USP17L13 | 3.31e-09 | 1475 | 110 | 34 | M19806 |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 5.25e-09 | 33 | 110 | 7 | M39503 | |
| Pathway | REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS | 6.45e-09 | 10 | 110 | 5 | M26977 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 1.17e-08 | 11 | 110 | 5 | M12484 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 1.17e-08 | 11 | 110 | 5 | MM14615 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.23e-08 | 37 | 110 | 7 | M27134 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.69e-08 | 221 | 110 | 13 | M27578 |
| Pathway | PID_NOTCH_PATHWAY | 1.69e-08 | 59 | 110 | 8 | M17 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.82e-08 | 39 | 110 | 7 | MM14601 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 EPGN USP17L18 EGF USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.44e-08 | 318 | 110 | 15 | MM15278 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.62e-08 | 41 | 110 | 7 | M27778 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.23e-08 | 13 | 110 | 5 | M47423 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.10e-08 | 27 | 110 | 6 | M39545 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 8.22e-08 | 48 | 110 | 7 | MM14987 | |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.25e-07 | 262 | 110 | 13 | MM15286 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.51e-07 | 32 | 110 | 6 | MM14854 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.67e-07 | 53 | 110 | 7 | M8276 | |
| Pathway | WP_FOCAL_ADHESION | RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 EGF TNR | 2.27e-07 | 187 | 110 | 11 | MM15913 |
| Pathway | WP_FOCAL_ADHESION | RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 EGF TNR | 4.24e-07 | 199 | 110 | 11 | M39402 |
| Pathway | KEGG_FOCAL_ADHESION | RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 EGF TNR | 4.24e-07 | 199 | 110 | 11 | M7253 |
| Pathway | REACTOME_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS | 4.29e-07 | 9 | 110 | 4 | MM14614 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS | 4.29e-07 | 9 | 110 | 4 | MM14613 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.21e-07 | 39 | 110 | 6 | MM14604 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L12 COPA USP17L20 USP17L11 USP17L5 USP17L10 MUC5B USP17L19 NR3C1 SSPOP F7 F10 PGR USP17L18 PROZ MEGF6 USP17L17 FURIN LYPD5 USP17L6P ADAMTS20 NR3C2 LTBP1 USP17L22 MUC5AC USP17L15 PROC USP17L13 | 5.60e-07 | 1389 | 110 | 29 | MM15307 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.70e-07 | 299 | 110 | 13 | M27574 |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 7.75e-07 | 66 | 110 | 7 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.75e-07 | 66 | 110 | 7 | M18 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 EFEMP2 MATN4 SCUBE1 FBLN2 FBN2 MEGF6 FURIN LTBP1 LTBP2 TNR LTBP4 | 7.85e-07 | 258 | 110 | 12 | MM14572 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.52e-07 | 68 | 110 | 7 | M27303 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.44e-06 | 140 | 110 | 9 | M587 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.66e-06 | 12 | 110 | 4 | M47532 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | HSPG2 MUC5B SSPOP CSPG5 ADAMTS20 MUC5AC NOTCH1 NOTCH2 NOTCH3 | 1.72e-06 | 143 | 110 | 9 | M27275 |
| Pathway | WP_CANCER_PATHWAYS | IL13RA1 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 DLL1 MST1 EGF JAG1 LRP6 NOTCH1 NOTCH2 NOTCH3 | 1.90e-06 | 507 | 110 | 16 | M48302 |
| Pathway | WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS | 2.38e-06 | 13 | 110 | 4 | M45518 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.65e-06 | 79 | 110 | 7 | M27643 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 3.41e-06 | 82 | 110 | 7 | MM15922 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.02e-06 | 84 | 110 | 7 | M3228 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 4.57e-06 | 5 | 110 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.57e-06 | 5 | 110 | 3 | MM14733 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 9.09e-06 | 6 | 110 | 3 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 9.09e-06 | 6 | 110 | 3 | M22074 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 9.09e-06 | 6 | 110 | 3 | M27068 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 9.79e-06 | 96 | 110 | 7 | M39834 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 9.87e-06 | 18 | 110 | 4 | M614 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.08e-05 | 38 | 110 | 5 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.08e-05 | 38 | 110 | 5 | MM15865 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.24e-05 | 19 | 110 | 4 | MM15594 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.58e-05 | 7 | 110 | 3 | M27199 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.58e-05 | 7 | 110 | 3 | MM14734 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 EGF TNR | 2.36e-05 | 302 | 110 | 11 | M39719 |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.52e-05 | 45 | 110 | 5 | M39571 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | HSPG2 EPM2A MUC5B SSPOP CSPG5 ADAMTS20 MUC5AC NOTCH1 NOTCH2 NOTCH3 | 2.55e-05 | 250 | 110 | 10 | M27554 |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.80e-05 | 46 | 110 | 5 | MM15971 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.12e-05 | 47 | 110 | 5 | M646 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.12e-05 | 47 | 110 | 5 | M7946 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 3.75e-05 | 9 | 110 | 3 | M39869 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.83e-05 | 49 | 110 | 5 | M618 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.91e-05 | 25 | 110 | 4 | M27879 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 EGF TNR | 4.74e-05 | 326 | 110 | 11 | MM15917 |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 5.33e-05 | 10 | 110 | 3 | MM15839 | |
| Pathway | WP_PI3KAKT_SIGNALING | RELN LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ITGB5 EGF TNR | 6.75e-05 | 339 | 110 | 11 | M39736 |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 7.29e-05 | 11 | 110 | 3 | M47865 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 7.29e-05 | 11 | 110 | 3 | M39647 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION | 8.00e-05 | 57 | 110 | 5 | MM14634 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 8.23e-05 | 30 | 110 | 4 | M27323 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 8.23e-05 | 30 | 110 | 4 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 8.23e-05 | 30 | 110 | 4 | MM15812 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.18e-05 | 94 | 110 | 6 | M1041 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 9.39e-05 | 31 | 110 | 4 | M592 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 9.66e-05 | 12 | 110 | 3 | M22020 | |
| Pathway | BIOCARTA_HES_PATHWAY | 9.66e-05 | 12 | 110 | 3 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 9.66e-05 | 12 | 110 | 3 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 9.66e-05 | 12 | 110 | 3 | M47533 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.03e-04 | 96 | 110 | 6 | M39581 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.11e-04 | 61 | 110 | 5 | M39540 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION | 1.11e-04 | 61 | 110 | 5 | M26993 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 1.25e-04 | 13 | 110 | 3 | M4470 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 1.25e-04 | 13 | 110 | 3 | MM1395 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.25e-04 | 13 | 110 | 3 | M47534 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.96e-04 | 15 | 110 | 3 | M27202 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.01e-04 | 154 | 110 | 7 | M39739 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.11e-04 | 38 | 110 | 4 | MM14874 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.40e-04 | 16 | 110 | 3 | M47424 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.44e-04 | 72 | 110 | 5 | M39403 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 CHD4 EPGN PGR MST1 EGF FURIN | 2.53e-04 | 532 | 110 | 13 | M27870 |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.60e-04 | 73 | 110 | 5 | MM15906 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.90e-04 | 17 | 110 | 3 | M39389 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF585A NR4A2 NR4A3 CHD3 E2F5 CHD4 NR4A1 NR3C1 PGR ZNF585B FURIN NR3C2 NR1I3 NOTCH1 NOTCH3 ZNF286A | 2.95e-04 | 768 | 110 | 16 | MM14851 |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.19e-04 | 118 | 110 | 6 | M39852 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.06e-27 | 21 | 133 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.06e-27 | 21 | 133 | 13 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.06e-27 | 21 | 133 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.06e-27 | 21 | 133 | 13 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.06e-27 | 21 | 133 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.06e-27 | 21 | 133 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.89e-27 | 22 | 133 | 13 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.93e-26 | 24 | 133 | 13 | 8995226 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 5.44e-26 | 33 | 133 | 14 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 15780755 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 9806828 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 20368735 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.22e-26 | 34 | 133 | 14 | 21448158 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.02e-25 | 25 | 133 | 13 | 21115691 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.53e-25 | 35 | 133 | 14 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.53e-25 | 35 | 133 | 14 | 21239494 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.04e-25 | 26 | 133 | 13 | 35816173 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.50e-25 | 36 | 133 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.01e-25 | 37 | 133 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.32e-24 | 29 | 133 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 6.45e-21 | 50 | 133 | 13 | 31806660 |
| Pubmed | NID2 HSPG2 RELN MATN2 LAMA1 LAMA3 LAMA5 CRELD2 LAMB1 LAMB2 LAMC1 SSPOP FBLN2 FBN2 MEGF6 LTBP1 LTBP2 LTBP4 | 8.42e-21 | 175 | 133 | 18 | 28071719 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 6.52e-19 | 15 | 133 | 9 | 15895400 | |
| Pubmed | HSPG2 MATN2 EFEMP2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 FBLN2 LTBP1 LTBP2 LTBP4 | 1.30e-16 | 167 | 133 | 15 | 22159717 | |
| Pubmed | 1.21e-15 | 10 | 133 | 7 | 9034910 | ||
| Pubmed | 1.25e-15 | 29 | 133 | 9 | 22613833 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 3.32e-15 | 11 | 133 | 7 | 21524702 | |
| Pubmed | 7.95e-15 | 12 | 133 | 7 | 9396756 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | NID2 HSPG2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NTN4 FBLN2 | 1.22e-14 | 79 | 133 | 11 | 18757743 |
| Pubmed | 1.72e-14 | 13 | 133 | 7 | 12682087 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | NID2 HSPG2 MATN2 EFEMP2 LAMA1 LAMB1 LAMB2 LAMC1 GRN LDLR ITGBL1 FBLN2 LTBP1 LTBP2 LTBP4 | 4.71e-14 | 248 | 133 | 15 | 24006456 |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 5.45e-14 | 26 | 133 | 8 | 34189436 | |
| Pubmed | NID2 HSPG2 MATN2 LAMA1 LAMB1 LAMB2 LAMC1 SSPOP FBLN2 ADAMTS20 | 6.03e-14 | 64 | 133 | 10 | 22261194 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 7.77e-14 | 8 | 133 | 6 | 9489770 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 COPA MATN2 LAMA1 DNER LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 GRN LRP1B LDLR ITGB5 FBN2 TXNDC5 MEGF8 FURIN OSBPL9 TMEM131L LRP6 LTBP1 LTBP2 NOTCH1 NOTCH2 NOTCH3 | 9.16e-14 | 1201 | 133 | 27 | 35696571 |
| Pubmed | 1.13e-13 | 16 | 133 | 7 | 17601529 | ||
| Pubmed | 2.92e-13 | 50 | 133 | 9 | 23658023 | ||
| Pubmed | 3.13e-13 | 18 | 133 | 7 | 11311202 | ||
| Pubmed | NID2 HSPG2 MATN2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 FBLN2 LTBP1 LTBP2 LTBP4 | 4.70e-13 | 146 | 133 | 12 | 27068509 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | EFEMP2 LAMA5 CRELD2 LAMB2 LAMC1 GRN VWCE CD163 STAB1 ITGBL1 FBLN2 MEGF6 MEGF8 LTBP1 LTBP4 NOTCH1 MEGF10 NOTCH2 NOTCH3 | 5.54e-13 | 560 | 133 | 19 | 21653829 |
| Pubmed | 7.58e-13 | 5 | 133 | 5 | 10964500 | ||
| Pubmed | 7.58e-13 | 5 | 133 | 5 | 12743034 | ||
| Pubmed | 7.58e-13 | 20 | 133 | 7 | 22911573 | ||
| Pubmed | HSPG2 MATN2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 F7 MST1 FBLN2 LTBP1 LTBP4 | 8.24e-13 | 153 | 133 | 12 | 25037231 | |
| Pubmed | HSPG2 MATN2 EFEMP2 LAMB1 LAMB2 GRN MEGF6 MEGF8 LTBP1 LTBP4 NOTCH1 | 1.14e-12 | 118 | 133 | 11 | 21078624 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.27e-12 | 11 | 133 | 6 | 23472759 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.27e-12 | 11 | 133 | 6 | 9187150 | |
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 4.54e-12 | 6 | 133 | 5 | 9506922 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 4.54e-12 | 6 | 133 | 5 | 19603167 | |
| Pubmed | 6.31e-12 | 26 | 133 | 7 | 24742657 | ||
| Pubmed | 1.36e-11 | 15 | 133 | 6 | 9264260 | ||
| Pubmed | 1.58e-11 | 7 | 133 | 5 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.58e-11 | 7 | 133 | 5 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.58e-11 | 7 | 133 | 5 | 24711412 | |
| Pubmed | 1.58e-11 | 7 | 133 | 5 | 14557481 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA4F HSPG2 ZNF585A OBSCN LAMA5 LAMB2 LAMB3 KDM6B DLL1 LDLR ITGB5 ZCCHC14 MEGF6 MEGF8 IER5L FURIN CHD5 UNKL MLLT6 LTBP4 NOTCH1 NOTCH2 SDHA | 3.67e-11 | 1105 | 133 | 23 | 35748872 |
| Pubmed | 4.21e-11 | 8 | 133 | 5 | 8872465 | ||
| Pubmed | 4.21e-11 | 8 | 133 | 5 | 12015298 | ||
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 4.21e-11 | 8 | 133 | 5 | 15465493 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 4.21e-11 | 8 | 133 | 5 | 23529140 | |
| Pubmed | 4.21e-11 | 8 | 133 | 5 | 9858718 | ||
| Pubmed | 4.21e-11 | 8 | 133 | 5 | 11044610 | ||
| Pubmed | 9.44e-11 | 9 | 133 | 5 | 11118901 | ||
| Pubmed | 9.44e-11 | 9 | 133 | 5 | 16245338 | ||
| Pubmed | USP17L21 ZAN USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 OR6X1 USP17L18 FBN2 EGF USP17L17 CNTNAP2 USP17L6P USP17L22 USP17L15 USP17L13 | 1.19e-10 | 674 | 133 | 18 | 37196079 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.25e-10 | 135 | 133 | 10 | 28675934 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.43e-10 | 97 | 133 | 9 | 27559042 | |
| Pubmed | 1.71e-10 | 40 | 133 | 7 | 27068110 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.88e-10 | 10 | 133 | 5 | 23665443 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 1.88e-10 | 10 | 133 | 5 | 16554364 | |
| Pubmed | 1.88e-10 | 10 | 133 | 5 | 24015274 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.88e-10 | 10 | 133 | 5 | 16100707 | |
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 2.04e-10 | 4 | 133 | 4 | 12820173 | |
| Pubmed | 2.04e-10 | 4 | 133 | 4 | 9299121 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 2.04e-10 | 4 | 133 | 4 | 35008625 | |
| Pubmed | 2.04e-10 | 4 | 133 | 4 | 8034675 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 2.04e-10 | 4 | 133 | 4 | 22390640 | |
| Pubmed | 2.04e-10 | 4 | 133 | 4 | 10551863 | ||
| Pubmed | 2.06e-10 | 41 | 133 | 7 | 22675208 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.06e-10 | 101 | 133 | 9 | 20551380 | |
| Pubmed | 2.67e-10 | 23 | 133 | 6 | 36239412 | ||
| Pubmed | 3.44e-10 | 11 | 133 | 5 | 10878608 | ||
| Pubmed | 3.44e-10 | 11 | 133 | 5 | 12866128 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 3.44e-10 | 11 | 133 | 5 | 15499562 | |
| Pubmed | 5.88e-10 | 12 | 133 | 5 | 16750824 | ||
| Pubmed | 5.88e-10 | 12 | 133 | 5 | 14732396 | ||
| Pubmed | 5.88e-10 | 12 | 133 | 5 | 15465494 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 7.73e-10 | 27 | 133 | 6 | 21791528 | |
| Pubmed | 8.45e-10 | 164 | 133 | 10 | 32409323 | ||
| Pubmed | 9.52e-10 | 13 | 133 | 5 | 36350252 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 9.52e-10 | 13 | 133 | 5 | 11578869 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 9.52e-10 | 13 | 133 | 5 | 31202705 | |
| Interaction | IGFL3 interactions | LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 GRN LRP1B LDLR FBN2 LRP2 NOTCH1 NOTCH2 NOTCH3 | 1.48e-15 | 75 | 129 | 13 | int:IGFL3 |
| Interaction | NTN5 interactions | 1.64e-14 | 24 | 129 | 9 | int:NTN5 | |
| Interaction | ZNF408 interactions | HSPG2 LAMA1 GRN VWCE CHAMP1 LRP1B LDLR FBLN2 FBN2 LRP2 LTBP1 LTBP2 LTBP4 NOTCH2 NOTCH3 | 2.55e-14 | 145 | 129 | 15 | int:ZNF408 |
| Interaction | FBXO2 interactions | NID2 HSPG2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 GRN LRP1B ITGB5 FBN2 MEGF8 JAG1 LRP2 TMEM131L LTBP4 NOTCH1 NOTCH2 NOTCH3 | 1.86e-13 | 411 | 129 | 21 | int:FBXO2 |
| Interaction | ZFP41 interactions | 2.71e-12 | 57 | 129 | 10 | int:ZFP41 | |
| Interaction | MFAP5 interactions | 3.97e-11 | 52 | 129 | 9 | int:MFAP5 | |
| Interaction | HOXA1 interactions | MKRN3 EFEMP2 LAMA5 CRELD2 LAMB2 GRN VWCE CD163 NTN4 FBLN2 MEGF6 MEGF8 UNKL LTBP1 LTBP4 NOTCH1 NOTCH3 | 1.28e-10 | 356 | 129 | 17 | int:HOXA1 |
| Interaction | SLURP1 interactions | NID2 LAMA3 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 GRN LDLR MEGF8 NOTCH2 | 1.43e-10 | 144 | 129 | 12 | int:SLURP1 |
| Interaction | IGSF5 interactions | 1.76e-10 | 14 | 129 | 6 | int:IGSF5 | |
| Interaction | CACNA1A interactions | HSPG2 MATN2 EFEMP2 LAMB1 GRN MEGF6 MEGF8 CNTNAP2 LTBP1 LTBP4 NOTCH1 | 4.03e-10 | 123 | 129 | 11 | int:CACNA1A |
| Interaction | CFC1 interactions | LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MEGF8 LRP6 LTBP4 NOTCH1 NOTCH2 | 5.23e-10 | 126 | 129 | 11 | int:CFC1 |
| Interaction | EDN3 interactions | HSPG2 LAMA5 CRELD2 LAMB2 LAMB3 LDLR MEGF8 LRP6 NOTCH1 NOTCH2 | 1.85e-09 | 108 | 129 | 10 | int:EDN3 |
| Interaction | NID2 interactions | 4.13e-09 | 86 | 129 | 9 | int:NID2 | |
| Interaction | PRG2 interactions | HSPG2 LAMA5 CRELD2 LAMB2 LAMB3 LAMC1 CHD3 LDLR FBN2 LRP6 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 4.24e-09 | 285 | 129 | 14 | int:PRG2 |
| Interaction | ATXN7 interactions | 3.38e-08 | 109 | 129 | 9 | int:ATXN7 | |
| Interaction | CCN6 interactions | 1.08e-07 | 19 | 129 | 5 | int:CCN6 | |
| Interaction | MAML3 interactions | 1.43e-07 | 20 | 129 | 5 | int:MAML3 | |
| Interaction | LAMA1 interactions | 2.13e-07 | 66 | 129 | 7 | int:LAMA1 | |
| Interaction | DEFA1 interactions | 2.57e-07 | 100 | 129 | 8 | int:DEFA1 | |
| Interaction | ATN1 interactions | 3.52e-07 | 187 | 129 | 10 | int:ATN1 | |
| Interaction | PRG3 interactions | 6.83e-07 | 49 | 129 | 6 | int:PRG3 | |
| Interaction | FOXD4L6 interactions | 6.83e-07 | 49 | 129 | 6 | int:FOXD4L6 | |
| Interaction | FBXO6 interactions | HSPG2 COPA LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 GRN MUC5B LDLR ITGB5 FBN2 MEGF8 TMEM131L LTBP1 LTBP4 SDHA | 7.39e-07 | 717 | 129 | 18 | int:FBXO6 |
| Interaction | PI15 interactions | 1.04e-06 | 83 | 129 | 7 | int:PI15 | |
| Interaction | SDF2L1 interactions | HSPG2 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 NR3C1 F10 PROZ MEGF8 LRP6 | 1.11e-06 | 322 | 129 | 12 | int:SDF2L1 |
| Interaction | SIRPD interactions | 1.32e-06 | 86 | 129 | 7 | int:SIRPD | |
| Interaction | LGALS1 interactions | NID2 LAMA5 LAMB1 GRN LDLR ITGB5 MEGF9 JAG1 LRP2 NOTCH1 NOTCH2 NOTCH3 | 1.53e-06 | 332 | 129 | 12 | int:LGALS1 |
| Interaction | TOP3B interactions | SEMA4F HSPG2 ZNF585A OBSCN LAMA5 LAMB2 LAMB3 GRN KDM6B DLL1 LDLR ITGB5 CNBP ZCCHC14 MEGF6 MEGF8 IER5L FURIN CHD5 UNKL MLLT6 LTBP4 NOTCH1 SEC23B NOTCH2 SDHA | 1.79e-06 | 1470 | 129 | 26 | int:TOP3B |
| Interaction | ELSPBP1 interactions | 2.08e-06 | 92 | 129 | 7 | int:ELSPBP1 | |
| Interaction | LTBP1 interactions | 2.08e-06 | 92 | 129 | 7 | int:LTBP1 | |
| Interaction | MANEA interactions | 2.31e-06 | 60 | 129 | 6 | int:MANEA | |
| Interaction | ZNF74 interactions | 2.38e-06 | 34 | 129 | 5 | int:ZNF74 | |
| Interaction | GFI1B interactions | 2.69e-06 | 136 | 129 | 8 | int:GFI1B | |
| Interaction | FBN2 interactions | 3.71e-06 | 65 | 129 | 6 | int:FBN2 | |
| Interaction | ZNF444 interactions | 5.39e-06 | 106 | 129 | 7 | int:ZNF444 | |
| Interaction | ZNF358 interactions | 5.76e-06 | 19 | 129 | 4 | int:ZNF358 | |
| Interaction | BTNL2 interactions | 7.09e-06 | 155 | 129 | 8 | int:BTNL2 | |
| Interaction | ZNF224 interactions | 7.17e-06 | 20 | 129 | 4 | int:ZNF224 | |
| Interaction | ZNF627 interactions | 7.17e-06 | 20 | 129 | 4 | int:ZNF627 | |
| Interaction | ZNF594 interactions | 8.80e-06 | 7 | 129 | 3 | int:ZNF594 | |
| Interaction | FGF4 interactions | 8.84e-06 | 44 | 129 | 5 | int:FGF4 | |
| Interaction | EGFL7 interactions | 1.00e-05 | 77 | 129 | 6 | int:EGFL7 | |
| Interaction | LY86 interactions | 1.11e-05 | 217 | 129 | 9 | int:LY86 | |
| Interaction | NID1 interactions | 1.37e-05 | 48 | 129 | 5 | int:NID1 | |
| Interaction | IL5RA interactions | 1.51e-05 | 124 | 129 | 7 | int:IL5RA | |
| Interaction | WNT3A interactions | 1.51e-05 | 49 | 129 | 5 | int:WNT3A | |
| Interaction | F7 interactions | 1.54e-05 | 24 | 129 | 4 | int:F7 | |
| Interaction | NOTCH2 interactions | LAMB2 GRN ZNF397 DLL1 FBN2 JAG1 LTBP1 LTBP4 NOTCH1 NOTCH2 NOTCH3 EPHA4 | 1.79e-05 | 423 | 129 | 12 | int:NOTCH2 |
| Interaction | FBN1 interactions | 1.84e-05 | 51 | 129 | 5 | int:FBN1 | |
| Interaction | ZSCAN21 interactions | 1.86e-05 | 128 | 129 | 7 | int:ZSCAN21 | |
| Interaction | MFNG interactions | 2.51e-05 | 27 | 129 | 4 | int:MFNG | |
| Interaction | CXCL5 interactions | 2.51e-05 | 27 | 129 | 4 | int:CXCL5 | |
| Interaction | LAMC1 interactions | 2.62e-05 | 135 | 129 | 7 | int:LAMC1 | |
| Interaction | ADAM30 interactions | 2.92e-05 | 56 | 129 | 5 | int:ADAM30 | |
| Interaction | TMPRSS6 interactions | 2.98e-05 | 10 | 129 | 3 | int:TMPRSS6 | |
| Interaction | ELN interactions | 3.36e-05 | 29 | 129 | 4 | int:ELN | |
| Interaction | ZNF517 interactions | 3.36e-05 | 29 | 129 | 4 | int:ZNF517 | |
| Interaction | WDR25 interactions | 3.47e-05 | 58 | 129 | 5 | int:WDR25 | |
| Interaction | LYPD1 interactions | 3.47e-05 | 58 | 129 | 5 | int:LYPD1 | |
| Interaction | LAMC2 interactions | 3.86e-05 | 30 | 129 | 4 | int:LAMC2 | |
| Interaction | NCOA1 interactions | 4.34e-05 | 146 | 129 | 7 | int:NCOA1 | |
| Interaction | ZNF664 interactions | 4.41e-05 | 31 | 129 | 4 | int:ZNF664 | |
| Interaction | DNAJC10 interactions | 4.60e-05 | 260 | 129 | 9 | int:DNAJC10 | |
| Interaction | PRELP interactions | 5.01e-05 | 32 | 129 | 4 | int:PRELP | |
| Interaction | PLAT interactions | 5.19e-05 | 63 | 129 | 5 | int:PLAT | |
| Interaction | CORIN interactions | 5.40e-05 | 12 | 129 | 3 | int:CORIN | |
| Interaction | VWCE interactions | 5.60e-05 | 64 | 129 | 5 | int:VWCE | |
| Interaction | FBLN2 interactions | 6.50e-05 | 66 | 129 | 5 | int:FBLN2 | |
| Interaction | ZKSCAN1 interactions | 6.50e-05 | 66 | 129 | 5 | int:ZKSCAN1 | |
| Interaction | DAB1 interactions | 6.52e-05 | 107 | 129 | 6 | int:DAB1 | |
| Interaction | ZNF709 interactions | 6.99e-05 | 13 | 129 | 3 | int:ZNF709 | |
| Interaction | TMEM106A interactions | 7.20e-05 | 214 | 129 | 8 | int:TMEM106A | |
| Interaction | NUFIP2 interactions | MATN2 EFEMP2 GRN CHD4 VWCE STAB1 FBLN2 MEGF6 LTBP2 LTBP4 NOTCH3 | 7.80e-05 | 417 | 129 | 11 | int:NUFIP2 |
| Interaction | BCAN interactions | 8.05e-05 | 36 | 129 | 4 | int:BCAN | |
| Interaction | DLK2 interactions | 8.05e-05 | 36 | 129 | 4 | int:DLK2 | |
| Interaction | SHANK3 interactions | ZAN EFEMP2 GRN ITGBL1 MEGF6 TNR LTBP4 NOTCH1 MEGF10 NOTCH2 SDHA NOTCH3 | 8.35e-05 | 496 | 129 | 12 | int:SHANK3 |
| Interaction | NOTCH3 interactions | 8.84e-05 | 113 | 129 | 6 | int:NOTCH3 | |
| Interaction | WNT10A interactions | 8.98e-05 | 37 | 129 | 4 | int:WNT10A | |
| Interaction | GREM2 interactions | 8.98e-05 | 37 | 129 | 4 | int:GREM2 | |
| Interaction | DLL1 interactions | 9.99e-05 | 38 | 129 | 4 | int:DLL1 | |
| Interaction | C1orf54 interactions | 1.01e-04 | 167 | 129 | 7 | int:C1orf54 | |
| Interaction | LAMA5 interactions | 1.07e-04 | 117 | 129 | 6 | int:LAMA5 | |
| Interaction | NR0B1 interactions | 1.22e-04 | 40 | 129 | 4 | int:NR0B1 | |
| Interaction | NCR3 interactions | 1.23e-04 | 120 | 129 | 6 | int:NCR3 | |
| Interaction | ZNF260 interactions | 1.35e-04 | 16 | 129 | 3 | int:ZNF260 | |
| Interaction | ZNF628 interactions | 1.35e-04 | 16 | 129 | 3 | int:ZNF628 | |
| Interaction | JAG1 interactions | 1.35e-04 | 41 | 129 | 4 | int:JAG1 | |
| Interaction | MBD1 interactions | 1.36e-04 | 77 | 129 | 5 | int:MBD1 | |
| Interaction | CRP interactions | 1.36e-04 | 77 | 129 | 5 | int:CRP | |
| Interaction | EFEMP1 interactions | 1.41e-04 | 123 | 129 | 6 | int:EFEMP1 | |
| Interaction | TAFA3 interactions | 1.44e-04 | 78 | 129 | 5 | int:TAFA3 | |
| Interaction | PTPRK interactions | 1.45e-04 | 177 | 129 | 7 | int:PTPRK | |
| Interaction | NELL1 interactions | 1.49e-04 | 42 | 129 | 4 | int:NELL1 | |
| Interaction | ZNF707 interactions | 1.53e-04 | 79 | 129 | 5 | int:ZNF707 | |
| Interaction | ADAM33 interactions | 1.53e-04 | 79 | 129 | 5 | int:ADAM33 | |
| Interaction | ZDHHC15 interactions | 1.54e-04 | 125 | 129 | 6 | int:ZDHHC15 | |
| Interaction | GLI4 interactions | 1.54e-04 | 125 | 129 | 6 | int:GLI4 | |
| Interaction | FNDC5 interactions | NID2 HSPG2 COPA MATN2 EFEMP2 LAMA5 LAMB1 LAMB2 LAMC1 GRN MUC5B CHD4 ITGB5 FBLN2 TXNDC5 FURIN OSBPL9 LTBP1 MUC5AC SEC23B NOTCH2 SDHA | 1.55e-04 | 1470 | 129 | 22 | int:FNDC5 |
| Interaction | ZNF57 interactions | 1.63e-04 | 17 | 129 | 3 | int:ZNF57 | |
| Interaction | MAML2 interactions | 1.63e-04 | 17 | 129 | 3 | int:MAML2 | |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.54e-21 | 79 | 133 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.66e-15 | 222 | 133 | 14 | chr4p16 |
| Cytoband | 7q22 | 4.60e-06 | 38 | 133 | 4 | 7q22 | |
| Cytoband | 13q34 | 1.90e-05 | 54 | 133 | 4 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 1.30e-04 | 88 | 133 | 4 | chr13q34 | |
| Cytoband | 19q13.12 | 1.22e-03 | 72 | 133 | 3 | 19q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 1.46e-03 | 167 | 133 | 4 | chr1q25 | |
| GeneFamily | Laminin subunits | 5.02e-14 | 12 | 91 | 7 | 626 | |
| GeneFamily | Nuclear hormone receptors | 4.68e-09 | 49 | 91 | 7 | 71 | |
| GeneFamily | Gla domain containing | 4.15e-07 | 13 | 91 | 4 | 1250 | |
| GeneFamily | Low density lipoprotein receptors | 4.15e-07 | 13 | 91 | 4 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 4.92e-07 | 4 | 91 | 3 | 628 | |
| GeneFamily | PHD finger proteins|NuRD complex | 2.63e-05 | 12 | 91 | 3 | 1305 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.31e-04 | 27 | 91 | 3 | 1253 | |
| GeneFamily | Netrins | 3.71e-04 | 6 | 91 | 2 | 661 | |
| GeneFamily | Fibulins | 6.88e-04 | 8 | 91 | 2 | 556 | |
| GeneFamily | CD molecules|Integrin beta subunits | 8.82e-04 | 9 | 91 | 2 | 1159 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF573 ZNF585A ZNF397 ZNF57 CHAMP1 ZNF585B RLF ZNF648 ZNF333 PRDM15 ZNF286A | 9.44e-04 | 718 | 91 | 11 | 28 |
| GeneFamily | PHD finger proteins | 1.10e-03 | 90 | 91 | 4 | 88 | |
| GeneFamily | CD molecules|Mucins | 4.94e-03 | 21 | 91 | 2 | 648 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 6.97e-03 | 25 | 91 | 2 | 74 | |
| GeneFamily | Fibronectin type III domain containing | 8.70e-03 | 160 | 91 | 4 | 555 | |
| GeneFamily | WD repeat domain containing | 1.04e-02 | 262 | 91 | 5 | 362 | |
| GeneFamily | Zinc fingers CCCH-type | 1.34e-02 | 35 | 91 | 2 | 73 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 RELN MATN2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 VWCE SSPOP NTN4 FBLN2 FBN2 LTBP1 LTBP2 TNR LTBP4 | 2.68e-25 | 191 | 132 | 23 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 RELN MATN2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 VWCE SSPOP NTN4 FBLN2 FBN2 LTBP1 LTBP2 TNR LTBP4 | 4.93e-25 | 196 | 132 | 23 | M3008 |
| Coexpression | NABA_MATRISOME | SEMA4F NID2 HSPG2 RELN MATN2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 MUC5B EPGN VWCE SSPOP F7 F10 MST1 NTN4 SCUBE1 FBLN2 FBN2 EGF MEGF6 MEGF8 MEGF9 CSPG5 ADAMTS20 LTBP1 LTBP2 TNR LTBP4 MUC5AC MEGF10 | 4.93e-24 | 1008 | 132 | 39 | MM17056 |
| Coexpression | NABA_MATRISOME | SEMA4F NID2 HSPG2 RELN MATN2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 MUC5B EPGN VWCE SSPOP F7 F10 MST1 NTN4 SCUBE1 FBLN2 FBN2 EGF MEGF6 MEGF8 MEGF9 CSPG5 ADAMTS20 LTBP1 LTBP2 TNR LTBP4 MUC5AC MEGF10 | 9.34e-24 | 1026 | 132 | 39 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | NID2 HSPG2 RELN MATN2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 VWCE SSPOP NTN4 FBLN2 FBN2 LTBP1 LTBP2 TNR LTBP4 | 3.67e-23 | 270 | 132 | 24 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | NID2 HSPG2 RELN MATN2 EFEMP2 LAMA1 LAMA3 NTNG1 LAMA5 CRELD2 LAMB1 LAMB2 LAMB3 LAMC1 MATN4 VWCE SSPOP NTN4 FBLN2 FBN2 LTBP1 LTBP2 TNR LTBP4 | 5.70e-23 | 275 | 132 | 24 | M5884 |
| Coexpression | NABA_BASEMENT_MEMBRANES | NID2 HSPG2 LAMA1 LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 NTN4 | 7.05e-17 | 40 | 132 | 11 | M5887 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.67e-16 | 86 | 132 | 13 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.63e-14 | 112 | 132 | 13 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.72e-12 | 160 | 132 | 13 | MM1155 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.60e-11 | 23 | 132 | 7 | M48001 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 5.32e-10 | 20 | 132 | 6 | MM17053 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | NID2 COPA MATN2 EFEMP2 LAMA1 LAMA3 LAMC1 ITGB5 FBLN2 FBN2 NOTCH2 | 6.00e-09 | 200 | 132 | 11 | M5930 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.25e-08 | 16 | 132 | 5 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.25e-08 | 16 | 132 | 5 | M2207 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.90e-08 | 135 | 132 | 9 | M5825 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 1.72e-07 | 166 | 132 | 9 | M1542 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | SELL IL13RA1 MATN2 NR4A2 NR4A1 LDLR ITGB5 FBLN2 FBN2 JAG1 LTBP2 LTBP4 | 2.58e-07 | 355 | 132 | 12 | M45758 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.26e-07 | 179 | 132 | 9 | MM660 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 5.42e-07 | 32 | 132 | 5 | M5903 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | EFEMP2 LAMA1 LAMB1 LAMB2 LAMC1 NR3C1 SCUBE1 FBN2 JAG1 LTBP4 NOTCH2 NOTCH3 | 6.10e-07 | 385 | 132 | 12 | M39264 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 8.63e-07 | 35 | 132 | 5 | MM17054 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | HSPG2 RELN MATN2 LAMA1 LAMA3 LAMB1 LAMB3 LAMC1 BCOR DLL1 JAG1 CSRP2 LTBP4 | 9.64e-07 | 479 | 132 | 13 | M2573 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | NID2 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 NR4A1 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 9.82e-07 | 647 | 132 | 15 | MM981 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | HSPG2 RELN MATN2 LAMA1 LAMA3 LAMB1 LAMB3 LAMC1 BCOR DLL1 JAG1 CSRP2 LTBP4 | 1.06e-06 | 483 | 132 | 13 | MM1082 |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.59e-06 | 71 | 132 | 6 | M2948 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL | 1.95e-06 | 115 | 132 | 7 | M45671 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | NID2 USP17L21 USP17L12 USP17L20 STXBP5 USP17L11 MATN2 EFEMP2 USP17L5 USP17L10 USP17L19 LDLR USP17L18 USP17L17 OSBPL9 USP17L6P USP17L22 LTBP4 USP17L15 USP17L13 | 2.40e-06 | 1198 | 132 | 20 | MM1062 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.47e-06 | 6 | 132 | 3 | M48000 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | MATN2 LAMB2 LAMC1 GRN MATN4 KDM6B LDLR MST1 FBLN2 TXNDC5 OSBPL9 LTBP4 | 3.61e-06 | 457 | 132 | 12 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | MATN2 LAMB2 LAMC1 GRN MATN4 KDM6B LDLR MST1 FBLN2 TXNDC5 OSBPL9 LTBP4 | 4.80e-06 | 470 | 132 | 12 | MM1053 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SEMA4F MUC5B EPGN F7 F10 MST1 SCUBE1 EGF MEGF6 MEGF8 MEGF9 CSPG5 ADAMTS20 MUC5AC MEGF10 | 4.91e-06 | 738 | 132 | 15 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SEMA4F MUC5B EPGN F7 F10 MST1 SCUBE1 EGF MEGF6 MEGF8 MEGF9 CSPG5 ADAMTS20 MUC5AC MEGF10 | 6.05e-06 | 751 | 132 | 15 | M5885 |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 6.86e-06 | 8 | 132 | 3 | M9884 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | NID2 EFEMP2 LAMB1 LAMB2 LAMC1 NR3C1 SLC40A1 JAG1 NOTCH1 NOTCH3 | 1.68e-05 | 365 | 132 | 10 | M39018 |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.88e-05 | 117 | 132 | 6 | M39300 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 2.96e-05 | 174 | 132 | 7 | M39126 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | NID2 HSPG2 EFEMP2 LAMB2 LAMC1 LDLR ITGB5 ITGBL1 SCUBE1 JAG1 LTBP2 WDR86 MEGF10 NOTCH3 | 3.39e-05 | 767 | 132 | 14 | M39209 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 3.54e-05 | 179 | 132 | 7 | M39308 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 4.14e-05 | 325 | 132 | 9 | M39053 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | HSPG2 EFEMP2 LAMB1 LAMB2 LAMB3 PGR ZCCHC14 NTN4 CSRP2 NR3C2 LTBP1 | 4.18e-05 | 493 | 132 | 11 | M19391 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | NID2 HSPG2 LAMB1 LAMB2 LAMC1 NR4A3 GRN NR4A1 NR3C1 LDLR STAB1 FBLN2 MEGF6 JAG1 CSRP2 | 4.26e-05 | 888 | 132 | 15 | M39049 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 5.00e-05 | 189 | 132 | 7 | M45678 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 5.43e-05 | 15 | 132 | 3 | MM402 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 6.64e-05 | 268 | 132 | 8 | M45796 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 6.92e-05 | 199 | 132 | 7 | M5268 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 6.92e-05 | 199 | 132 | 7 | M5406 | |
| Coexpression | HALLMARK_TNFA_SIGNALING_VIA_NFKB | 7.15e-05 | 200 | 132 | 7 | M5890 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | NID2 RELN LAMA1 NR4A2 LAMB1 MATN4 ITGB5 NTN4 SCUBE1 FBLN2 JAG1 CSRP2 LRP2 SYT13 NOTCH1 MBNL3 | 1.03e-04 | 1074 | 132 | 16 | M1941 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 1.04e-04 | 286 | 132 | 8 | M45746 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 1.16e-04 | 216 | 132 | 7 | M2122 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | IL13RA1 NR4A2 GRN NR4A1 ZCCHC14 ITGBL1 CSPG5 JAG1 CSRP2 CNTNAP2 | 1.19e-04 | 461 | 132 | 10 | M14127 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.32e-04 | 467 | 132 | 10 | M1347 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL | 1.38e-04 | 52 | 132 | 4 | M45780 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RELN STXBP5 DNER LAMA3 NTNG1 LAMA5 CHD3 VWCE SSPOP LRP1B MEGF6 MEGF9 CSPG5 CHD5 CNTNAP2 SYT13 | 1.44e-04 | 1106 | 132 | 16 | M39071 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | NID2 USP17L21 USP17L12 USP17L20 USP17L11 CRELD2 USP17L5 USP17L10 USP17L19 NR4A1 USP17L18 USP17L17 USP17L6P LTBP2 USP17L22 USP17L15 USP17L13 | 1.47e-04 | 1226 | 132 | 17 | MM979 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | NID2 COPA LAMB1 LAMC1 NR3C1 ITGB5 JAG1 LTBP1 LTBP2 NOTCH1 NOTCH2 NOTCH3 | 1.75e-04 | 681 | 132 | 12 | M39175 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.76e-04 | 484 | 132 | 10 | MM999 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | NID2 EFEMP2 LAMB1 LAMB2 LAMC1 NR4A3 GRN NR4A1 NR3C1 ITGB5 JAG1 NOTCH2 NOTCH3 | 1.95e-04 | 795 | 132 | 13 | M39050 |
| Coexpression | NAGASHIMA_EGF_SIGNALING_UP | 1.97e-04 | 57 | 132 | 4 | M16311 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 2.10e-04 | 238 | 132 | 7 | M12004 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | 2.21e-04 | 240 | 132 | 7 | M6413 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN | 2.27e-04 | 170 | 132 | 6 | M9445 | |
| Coexpression | KAYO_AGING_MUSCLE_UP | 2.32e-04 | 242 | 132 | 7 | M16050 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 2.42e-04 | 172 | 132 | 6 | M11585 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 2.58e-04 | 174 | 132 | 6 | M45676 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 2.91e-04 | 178 | 132 | 6 | M17079 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | NID2 RELN MATN2 NR4A2 LAMB1 LAMC1 NR4A1 ITGB5 FBLN2 ASTN1 LTBP1 LTBP2 | 2.95e-04 | 721 | 132 | 12 | M1999 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 2.96e-04 | 115 | 132 | 5 | M45752 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 2.96e-04 | 115 | 132 | 5 | M19068 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 3.18e-04 | 337 | 132 | 8 | MM16606 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.24e-04 | 338 | 132 | 8 | MM17064 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL | 3.28e-04 | 182 | 132 | 6 | M45771 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 3.34e-04 | 27 | 132 | 3 | M47994 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 3.58e-04 | 185 | 132 | 6 | M8792 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.58e-04 | 343 | 132 | 8 | M5883 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | 3.82e-04 | 437 | 132 | 9 | M15981 | |
| Coexpression | JIANG_MELANOMA_TRM5_CD8 | 4.01e-04 | 189 | 132 | 6 | M48969 | |
| Coexpression | TGFB_UP.V1_UP | 4.01e-04 | 189 | 132 | 6 | M2839 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 4.01e-04 | 440 | 132 | 9 | M39039 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.14e-04 | 29 | 132 | 3 | MM17055 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 4.19e-04 | 124 | 132 | 5 | M45686 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 4.20e-04 | 267 | 132 | 7 | M12890 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 4.25e-04 | 352 | 132 | 8 | M17471 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 4.36e-04 | 192 | 132 | 6 | M4277 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 4.48e-04 | 193 | 132 | 6 | M39321 | |
| Coexpression | CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY | 4.59e-04 | 30 | 132 | 3 | M10778 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 4.60e-04 | 194 | 132 | 6 | M39122 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 4.69e-04 | 272 | 132 | 7 | MM3825 | |
| Coexpression | GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP | 4.73e-04 | 195 | 132 | 6 | M3319 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 4.73e-04 | 195 | 132 | 6 | M3170 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 4.86e-04 | 196 | 132 | 6 | M8683 | |
| Coexpression | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN | 4.90e-04 | 274 | 132 | 7 | M13014 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 5.12e-04 | 276 | 132 | 7 | M3063 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN | 5.13e-04 | 198 | 132 | 6 | M8750 | |
| Coexpression | GSE4142_NAIVE_VS_GC_BCELL_UP | 5.26e-04 | 199 | 132 | 6 | M6375 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN | 5.26e-04 | 199 | 132 | 6 | M6523 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP | 5.40e-04 | 200 | 132 | 6 | M385 | |
| Coexpression | GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 5.40e-04 | 200 | 132 | 6 | M364 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | 5.40e-04 | 200 | 132 | 6 | M3407 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | IL13RA1 RELN LAMA1 NR4A2 NTNG1 LAMA5 LAMC1 NR4A1 JAG1 CSRP2 LTBP1 NOTCH2 NOTCH3 | 7.80e-09 | 293 | 116 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | RELN EFEMP2 LAMA1 LAMB1 LAMB3 KDM6B SSPOP F7 SLC40A1 F10 CD163 MST1 NTN4 FBLN2 FBN2 MEGF6 IER5L FURIN CNTNAP2 MLLT6 LTBP1 LTBP2 | 1.50e-08 | 982 | 116 | 22 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | NID2 HSPG2 IL13RA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 NR4A1 DLL1 STAB1 FBLN2 JAG1 LTBP2 LTBP4 | 3.13e-08 | 459 | 116 | 15 | GSM777037_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 1.83e-07 | 155 | 116 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | NID2 HSPG2 IL13RA1 MATN2 EFEMP2 LAMB1 LAMB2 LAMC1 NR4A1 ITGB5 JAG1 LTBP2 LTBP4 NOTCH3 | 1.95e-07 | 455 | 116 | 14 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | HSPG2 IL13RA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 NR4A1 DLL1 STAB1 FBLN2 JAG1 LTBP2 LTBP4 | 2.00e-07 | 456 | 116 | 14 | GSM777032_500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | NID2 EFEMP2 LAMA1 LAMB1 LAMB2 NR4A1 KDM6B DLL1 MST1 SCUBE1 FBN2 EGF MEGF6 IER5L FURIN JAG1 LRP2 ASTN1 MLLT6 LTBP1 LTBP2 WDR86 LTBP4 NOTCH2 EPHA4 | 2.77e-07 | 1466 | 116 | 25 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 3.11e-07 | 165 | 116 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | NID2 HSPG2 IL13RA1 MATN2 LAMB1 LAMB2 LAMC1 NR4A1 ITGB5 FBLN2 JAG1 LTBP1 LTBP4 | 9.81e-07 | 445 | 116 | 13 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | HSPG2 IL13RA1 MATN2 EFEMP2 LAMA5 LAMB1 LAMB2 LAMC1 NR4A1 ITGB5 JAG1 LTBP4 NOTCH3 | 1.20e-06 | 453 | 116 | 13 | GSM777067_500 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | HSPG2 RELN EFEMP2 LAMA1 LAMB1 SLC40A1 NTN4 FBLN2 MEGF6 MLLT6 WDR86 | 1.48e-06 | 320 | 116 | 11 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.48e-06 | 65 | 116 | 6 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 1.55e-06 | 148 | 116 | 8 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | HSPG2 IL13RA1 MATN2 EFEMP2 LAMA5 LAMB1 LAMB2 LAMC1 NR4A1 ITGB5 LTBP1 LTBP4 NOTCH3 | 1.64e-06 | 466 | 116 | 13 | GSM777050_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | NID2 LAMA1 LAMB1 LAMC1 DLL1 FBN2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 EPHA4 | 1.90e-06 | 398 | 116 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | NID2 HSPG2 IL13RA1 DNER LAMA3 LAMB1 LAMB3 LAMC1 GRN LDLR SLC40A1 ITGB5 NTN4 TXNDC5 FURIN LTBP2 | 3.89e-06 | 761 | 116 | 16 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | HSPG2 IL13RA1 RELN EFEMP2 LAMA1 LAMB1 NR4A1 KDM6B SLC40A1 ITGB5 NTN4 FBLN2 FBN2 EGF MEGF6 FURIN MLLT6 LTBP1 WDR86 EPHA4 | 4.07e-06 | 1153 | 116 | 20 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | HSPG2 IL13RA1 MATN2 LAMB1 LAMB2 LAMC1 NR4A1 ITGB5 ITGBL1 FBLN2 LTBP1 LTBP4 | 4.95e-06 | 437 | 116 | 12 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | NID2 HSPG2 IL13RA1 RELN LAMB1 LAMC1 STAB1 JAG1 ASTN1 LTBP1 LTBP2 LTBP4 | 5.19e-06 | 439 | 116 | 12 | GSM777059_500 |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | IL13RA1 EFEMP2 CHD3 KDM6B SLC40A1 ITGB5 NTN4 FBLN2 FBN2 MEGF6 FURIN LTBP1 WDR86 EPHA4 | 6.75e-06 | 615 | 116 | 14 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000 | IL13RA1 RELN LAMA5 LAMC1 CHD4 NR3C1 DLL1 ITGB5 STAB1 NTN4 TXNDC5 EGF ENTPD3 LRP2 LTBP1 WDR86 | 1.28e-05 | 837 | 116 | 16 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | NID2 MATN2 LAMA1 LAMA5 LAMB1 KDM6B DLL1 MST1 SCUBE1 IER5L JAG1 LRP2 ASTN1 LTBP2 WDR86 NOTCH2 ZNF286A EPHA4 | 2.11e-05 | 1075 | 116 | 18 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MATN2 EFEMP2 LAMA1 NTNG1 LAMB1 NR4A1 SLC40A1 ITGB5 SCUBE1 FBN2 TXNDC5 JAG1 LTBP4 MBNL3 NOTCH2 | 2.19e-05 | 777 | 116 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 2.25e-05 | 62 | 116 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 2.58e-05 | 217 | 116 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 2.63e-05 | 64 | 116 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | IL13RA1 RELN LAMA1 NR4A2 NTNG1 LAMA5 LAMB2 LAMC1 NR4A1 NR3C1 JAG1 CSRP2 LRP2 LTBP1 NOTCH2 NOTCH3 | 3.32e-05 | 905 | 116 | 16 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | IL13RA1 RELN LAMA1 LAMA5 LAMC1 DLL1 ITGB5 NTN4 TXNDC5 JAG1 ENTPD3 LRP2 LTBP1 NOTCH1 EPHA4 | 3.58e-05 | 811 | 116 | 15 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | HSPG2 IL13RA1 RELN LAMB1 LAMC1 NR4A1 STAB1 JAG1 LTBP1 LTBP2 LTBP4 | 3.66e-05 | 450 | 116 | 11 | GSM777063_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_200 | 3.73e-05 | 167 | 116 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | SEMA4F NTNG1 ZFAND4 MEGF9 JAG1 ADAMTS20 LTBP1 SYT13 MEGF10 EPHA4 | 4.24e-05 | 377 | 116 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.84e-05 | 307 | 116 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 5.02e-05 | 175 | 116 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.14e-05 | 120 | 116 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | SEMA4F NTNG1 ZCCHC14 FBLN2 MEGF9 ADAMTS20 LTBP1 SYT13 MEGF10 EPHA4 | 5.64e-05 | 390 | 116 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | SEMA4F LAMA3 NTNG1 ZFAND4 ZCCHC14 NTN4 FBLN2 MEGF9 JAG1 ADAMTS20 LTBP1 SYT13 MEGF10 EPHA4 | 7.87e-05 | 769 | 116 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | 7.87e-05 | 406 | 116 | 10 | gudmap_developingKidney_e15.5_S-shaped body_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | MATN2 EFEMP2 LAMA1 NTNG1 LAMB1 NR4A1 SLC40A1 ITGB5 SCUBE1 FBN2 JAG1 LTBP4 MBNL3 NOTCH2 | 8.32e-05 | 773 | 116 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_500 | MKRN3 LAMA1 NR4A3 DLL1 SCUBE1 CNTNAP2 LRP2 ADAMTS20 ASTN1 WDR86 IGLON5 | 8.59e-05 | 495 | 116 | 11 | PCBC_ECTO_500 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500 | MKRN3 RELN NR4A3 KDM6B DLL1 SSPOP SLC40A1 IER5L LRP2 LTBP2 WDR86 | 8.59e-05 | 495 | 116 | 11 | PCBC_ratio_ECTO_vs_SC_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | 8.73e-05 | 132 | 116 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | MKRN3 LAMA1 NR4A3 DLL1 SCUBE1 CNTNAP2 LRP2 ADAMTS20 ASTN1 WDR86 IGLON5 | 8.90e-05 | 497 | 116 | 11 | PCBC_ECTO_fibroblast_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | NID2 LAMA1 LAMA5 LAMB1 LAMC1 DLL1 FBN2 JAG1 CSRP2 LRP2 LTBP1 NOTCH1 NOTCH2 EPHA4 | 9.53e-05 | 783 | 116 | 14 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.00e-04 | 418 | 116 | 10 | PCBC_ratio_MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.02e-04 | 196 | 116 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | MKRN3 SEMA4F RELN DNER NTNG1 SLC40A1 ZFAND4 FBN2 ADAMTS20 MBNL3 | 1.06e-04 | 421 | 116 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MATN2 LAMA1 NR4A2 NTNG1 LAMB1 NR4A1 SLC40A1 ITGB5 SCUBE1 FBLN2 LTBP4 MBNL3 NOTCH2 EPHA4 | 1.09e-04 | 793 | 116 | 14 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_100 | 1.43e-04 | 91 | 116 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 1.44e-04 | 19 | 116 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | SEMA4F DNER NTNG1 LAMB1 LAMC1 KDM6B ZCCHC14 FBN2 ENTPD3 ADAMTS20 ASTN1 LTBP1 MEGF10 EPHA4 | 1.51e-04 | 818 | 116 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | MKRN3 SEMA4F RELN DNER NR4A2 NTNG1 BCOR SLC40A1 ZFAND4 FBN2 ADAMTS20 LRP6 MBNL3 ZNF286A | 1.52e-04 | 819 | 116 | 14 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 1.76e-04 | 364 | 116 | 9 | GSM854276_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | STXBP5L NR4A2 LAMB2 CHD3 DLL1 ZFAND4 SCUBE1 MEGF9 CNTNAP2 ASTN1 LTBP4 IGLON5 ZNF286A | 1.84e-04 | 732 | 116 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.93e-04 | 97 | 116 | 5 | GSM777043_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.99e-04 | 370 | 116 | 9 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | IL13RA1 RELN NR4A2 LAMA5 NR4A1 JAG1 CSRP2 LRP2 NOTCH2 NOTCH3 | 2.03e-04 | 456 | 116 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.18e-04 | 156 | 116 | 6 | ratio_MESO_vs_SC_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.29e-04 | 297 | 116 | 8 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_500 | 2.67e-04 | 385 | 116 | 9 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | MATN2 EFEMP2 LAMA1 LAMB1 NR4A1 ITGB5 SCUBE1 FBLN2 FBN2 JAG1 LTBP4 MBNL3 NOTCH2 | 2.92e-04 | 768 | 116 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_200 | 2.96e-04 | 24 | 116 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.04e-04 | 166 | 116 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | MKRN3 RELN LAMA1 DNER MATN4 LRP1B F7 SCUBE1 CSPG5 CNTNAP2 LRP2 ADAMTS20 WDR86 IGLON5 MEGF10 | 3.30e-04 | 992 | 116 | 15 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | RELN LAMA1 NR4A3 SCUBE1 CNTNAP2 LRP2 ADAMTS20 ASTN1 WDR86 IGLON5 | 3.42e-04 | 487 | 116 | 10 | PCBC_ECTO_blastocyst_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.82e-04 | 243 | 116 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 3.93e-04 | 63 | 116 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k3 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 4.15e-04 | 409 | 116 | 9 | GSM605823_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.21e-04 | 247 | 116 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 4.30e-04 | 411 | 116 | 9 | GSM538239_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.31e-04 | 248 | 116 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SEMA4F DNER LAMA3 NTNG1 LAMB3 LAMC1 KDM6B RLF ENTPD3 ASTN1 SYT13 MEGF10 EPHA4 | 4.63e-04 | 806 | 116 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 4.69e-04 | 416 | 116 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | 5.38e-04 | 424 | 116 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#2_top-relative-expression-ranked_500 | 5.57e-04 | 186 | 116 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 5.75e-04 | 428 | 116 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 5.85e-04 | 429 | 116 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | MKRN3 SEMA4F DNER NR4A2 NTNG1 NR4A3 NR4A1 ZFAND4 ADAMTS20 ASTN1 SYT13 MEGF10 EPHA4 | 5.89e-04 | 827 | 116 | 13 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.89e-04 | 188 | 116 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000_k2 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | NID2 MATN2 LAMB1 LAMB2 LAMB3 LAMC1 VWCE MST1 PROZ IER5L JAG1 CSRP2 LRP2 NR1I3 MBNL3 | 5.92e-04 | 1049 | 116 | 15 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 6.06e-04 | 189 | 116 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.70e-04 | 349 | 116 | 8 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_200 | 7.02e-04 | 32 | 116 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_500 | 7.25e-04 | 74 | 116 | 4 | gudmap_developingKidney_e15.5_S-shaped body_500_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | NID2 HSPG2 LAMA1 NR4A2 LAMB1 LAMC1 NR4A1 SLC40A1 STAB1 SCUBE1 JAG1 LTBP4 NOTCH1 | 7.27e-04 | 846 | 116 | 13 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | SEMA4F DNER LAMB1 MATN4 FBN2 GTF3C2 MEGF9 ASTN1 LTBP1 SYT13 MEGF10 ZNF286A EPHA4 | 7.59e-04 | 850 | 116 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.68e-04 | 131 | 116 | 5 | ratio_MESO_vs_SC_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_100 | 7.69e-04 | 33 | 116 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | SEMA4F STXBP5L NTNG1 CHD3 NR3C1 ZFAND4 FBLN2 ASTN1 NR3C2 LTBP1 LTBP4 IGLON5 MBNL3 EPHA4 | 8.08e-04 | 967 | 116 | 14 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | SEMA4F STXBP5L NTNG1 NR4A3 CHD3 NR3C1 DLL1 ITGB5 ZFAND4 FBLN2 CSRP2 ASTN1 LTBP2 LTBP4 | 8.58e-04 | 973 | 116 | 14 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 8.80e-04 | 364 | 116 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | SEMA4F STXBP5L NTNG1 LAMA5 CHD3 E2F5 NR3C1 DLL1 SCUBE1 FBLN2 CNTNAP2 LRP2 ASTN1 LTBP4 | 8.83e-04 | 976 | 116 | 14 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.83e-04 | 78 | 116 | 4 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 8.83e-04 | 78 | 116 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | MKRN3 NID2 IL13RA1 EFEMP2 DNER NTNG1 SSPOP LRP1B NTN4 SCUBE1 FBLN2 FBN2 IER5L LRP2 LTBP2 | 9.09e-04 | 1094 | 116 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | MKRN3 RELN PLB1 LAMA1 NR4A3 KDM6B DLL1 SSPOP SLC40A1 SCUBE1 IER5L LRP2 LTBP2 WDR86 | 9.74e-04 | 986 | 116 | 14 | PCBC_ratio_ECTO_vs_SC_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | MKRN3 RELN STXBP5L MATN2 LAMA1 DNER DLL1 LRP1B SCUBE1 CSPG5 CNTNAP2 LRP2 IGLON5 MEGF10 | 9.74e-04 | 986 | 116 | 14 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SEMA4F RELN STXBP5L CHD3 BCOR DLL1 SCUBE1 CNTNAP2 LRP2 ASTN1 LTBP1 IGLON5 MBNL3 EPHA4 | 9.74e-04 | 986 | 116 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 1.08e-03 | 37 | 116 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | NID2 IL13RA1 MATN2 LAMB2 GRN NR3C1 NTN4 ITGBL1 FBLN2 LRP2 LTBP2 LTBP4 | 1.13e-03 | 778 | 116 | 12 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.15e-03 | 214 | 116 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID2 HSPG2 COPA MATN2 LAMB1 LAMB2 LAMC1 ITGB5 ITGBL1 FBLN2 LTBP1 LTBP4 | 4.20e-13 | 196 | 126 | 12 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID2 HSPG2 COPA MATN2 LAMB1 LAMB2 LAMC1 ITGB5 ITGBL1 FBLN2 LTBP1 LTBP4 | 4.20e-13 | 196 | 126 | 12 | 787c6cd92035e0b1108c2c086c42a229016e476b |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ZAN STXBP5L LAMA1 OBSCN MUC5B SSPOP LRP1B FBN2 LRP2 ADAMTS20 | 5.35e-12 | 184 | 126 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ZAN STXBP5L LAMA1 OBSCN MUC5B SSPOP LRP1B FBN2 LRP2 ADAMTS20 | 5.35e-12 | 184 | 126 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ZAN STXBP5L LAMA1 OBSCN MUC5B SSPOP LRP1B FBN2 LRP2 ADAMTS20 | 5.35e-12 | 184 | 126 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | EFEMP2 LAMB1 LAMC1 SLC40A1 F10 ITGBL1 FBLN2 CSRP2 LTBP1 LTBP2 LTBP4 | 1.32e-11 | 200 | 126 | 11 | f6be0f24e607abb9007823a54fb0b24d04990a89 |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.24e-10 | 183 | 126 | 10 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-10 | 191 | 126 | 10 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-10 | 195 | 126 | 10 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | LAMA1 LAMB2 NR4A1 LDLR ITGB5 LTBP1 NOTCH1 MEGF10 NOTCH2 NOTCH3 | 2.55e-10 | 197 | 126 | 10 | 61749ccafeb938c310cff1de5ff924a1c794325a |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | LAMA1 LAMB2 NR4A1 LDLR ITGB5 LTBP1 NOTCH1 MEGF10 NOTCH2 NOTCH3 | 2.55e-10 | 197 | 126 | 10 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MATN2 LAMB1 LAMC1 ITGB5 FBLN2 TXNDC5 CSRP2 LTBP1 LTBP4 NOTCH2 | 2.55e-10 | 197 | 126 | 10 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.80e-09 | 190 | 126 | 9 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-09 | 192 | 126 | 9 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-09 | 192 | 126 | 9 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-09 | 193 | 126 | 9 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-09 | 195 | 126 | 9 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-09 | 196 | 126 | 9 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.99e-09 | 196 | 126 | 9 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-09 | 196 | 126 | 9 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-09 | 197 | 126 | 9 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.21e-09 | 197 | 126 | 9 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 5.21e-09 | 197 | 126 | 9 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-09 | 198 | 126 | 9 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-09 | 200 | 126 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-09 | 200 | 126 | 9 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 126 | 9 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 126 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 126 | 9 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 126 | 9 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 126 | 9 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.95e-09 | 200 | 126 | 9 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-08 | 160 | 126 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-08 | 160 | 126 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 2.64e-08 | 167 | 126 | 8 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.32e-08 | 172 | 126 | 8 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-08 | 178 | 126 | 8 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-08 | 180 | 126 | 8 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-08 | 186 | 126 | 8 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.08e-08 | 186 | 126 | 8 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.08e-08 | 186 | 126 | 8 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.33e-08 | 187 | 126 | 8 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.60e-08 | 188 | 126 | 8 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-08 | 189 | 126 | 8 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-08 | 189 | 126 | 8 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-08 | 192 | 126 | 8 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.76e-08 | 192 | 126 | 8 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-08 | 192 | 126 | 8 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.76e-08 | 192 | 126 | 8 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.08e-08 | 193 | 126 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.08e-08 | 193 | 126 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.08e-08 | 193 | 126 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.41e-08 | 194 | 126 | 8 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-08 | 195 | 126 | 8 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.75e-08 | 195 | 126 | 8 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-08 | 195 | 126 | 8 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-08 | 195 | 126 | 8 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.10e-08 | 196 | 126 | 8 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.10e-08 | 196 | 126 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.46e-08 | 197 | 126 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-08 | 197 | 126 | 8 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.84e-08 | 198 | 126 | 8 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.84e-08 | 198 | 126 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-07 | 199 | 126 | 8 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.02e-07 | 199 | 126 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 199 | 126 | 8 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-07 | 199 | 126 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-07 | 199 | 126 | 8 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | distal-mesenchymal-Myofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-07 | 199 | 126 | 8 | 79917b5225cb45b4a0ea937f79f1752346e4346e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-07 | 199 | 126 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-07 | 199 | 126 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-07 | 199 | 126 | 8 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 199 | 126 | 8 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.06e-07 | 200 | 126 | 8 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | distal-1-mesenchymal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 200 | 126 | 8 | 7623f82bd85a0ff7e2097e9281551208dfc602a8 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-07 | 200 | 126 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-07 | 200 | 126 | 8 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-07 | 200 | 126 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-07 | 200 | 126 | 8 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | distal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 200 | 126 | 8 | 7a79a2de78325d4f1c4535969106a0a44249028c | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.06e-07 | 200 | 126 | 8 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-07 | 200 | 126 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-07 | 200 | 126 | 8 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-07 | 200 | 126 | 8 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-07 | 155 | 126 | 7 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 3.01e-07 | 155 | 126 | 7 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.89e-07 | 161 | 126 | 7 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-07 | 169 | 126 | 7 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-07 | 169 | 126 | 7 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-07 | 174 | 126 | 7 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.83e-07 | 175 | 126 | 7 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.37e-07 | 177 | 126 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.37e-07 | 177 | 126 | 7 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.37e-07 | 177 | 126 | 7 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.37e-07 | 177 | 126 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.25e-07 | 180 | 126 | 7 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.25e-07 | 180 | 126 | 7 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| Computational | Adhesion molecules. | SELL RELN EFEMP2 LAMA3 LAMA5 LAMB1 LAMB2 LAMB3 ITGB5 ITGBL1 FBN2 | 1.41e-08 | 141 | 86 | 11 | MODULE_122 |
| Computational | Metal / Ca ion binding. | 1.06e-06 | 133 | 86 | 9 | MODULE_324 | |
| Computational | DRG (dorsal root ganglia) genes. | HSPG2 NR4A2 LAMA5 LAMB1 LAMB2 NR4A1 LDLR ITGB5 STAB1 FBLN2 MEGF9 LTBP1 LTBP2 NOTCH3 | 1.90e-06 | 384 | 86 | 14 | MODULE_2 |
| Computational | Lung genes. | SELL HSPG2 IL13RA1 LAMA5 LAMB2 GRN NR4A1 LDLR ITGB5 CD163 STAB1 MEGF9 LTBP2 NOTCH3 | 7.86e-06 | 434 | 86 | 14 | MODULE_5 |
| Computational | Placenta genes. | HSPG2 LAMA5 LAMB2 GRN ITGB5 STAB1 FBLN2 FBN2 FURIN JAG1 LTBP1 LTBP2 TNR NOTCH3 | 1.63e-05 | 463 | 86 | 14 | MODULE_38 |
| Computational | Ovary genes. | NID2 HSPG2 NR4A2 LAMB1 LAMB2 NR4A1 LDLR ITGB5 STAB1 LTBP1 LTBP2 NOTCH3 | 3.37e-05 | 368 | 86 | 12 | MODULE_1 |
| Computational | Trachea genes. | HSPG2 LAMA5 LAMB2 GRN MUC5B NR4A1 LDLR ITGB5 STAB1 FBLN2 LTBP1 NOTCH3 | 1.07e-04 | 415 | 86 | 12 | MODULE_6 |
| Computational | Blood coagulation factors. | 1.31e-04 | 33 | 86 | 4 | MODULE_131 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | HSPG2 LAMB2 LDLR ITGB5 LECT2 F10 CD163 STAB1 MST1 FBN2 MEGF9 PROC | 2.43e-04 | 453 | 86 | 12 | MODULE_24 |
| Computational | Serine proteases. | 2.54e-04 | 39 | 86 | 4 | MODULE_109 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | HSPG2 NTNG1 LAMB2 GRN MUC5B NR4A1 LDLR ITGB5 LECT2 F10 CD163 STAB1 MST1 FBLN2 FBN2 FURIN PROC | 2.80e-04 | 835 | 86 | 17 | MODULE_88 |
| Computational | Genes in the cancer module 107. | 4.13e-04 | 79 | 86 | 5 | MODULE_107 | |
| Computational | Catabolic peptidases. | 7.14e-04 | 89 | 86 | 5 | MODULE_209 | |
| Computational | Genes in the cancer module 55. | HSPG2 NTNG1 LAMB2 GRN MUC5B NR4A1 LDLR ITGB5 LECT2 F10 CD163 STAB1 MST1 FBN2 FURIN PROC | 8.12e-04 | 832 | 86 | 16 | MODULE_55 |
| Computational | Genes in the cancer module 172. | 1.01e-03 | 96 | 86 | 5 | MODULE_172 | |
| Computational | Liver genes - metabolism and xenobiotics. | HSPG2 NTNG1 LAMB2 F7 ITGB5 LECT2 F10 STAB1 MST1 ITGBL1 FURIN PROC | 1.66e-03 | 563 | 86 | 12 | MODULE_23 |
| Drug | AC1L1G72 | 8.99e-12 | 11 | 121 | 6 | CID000003553 | |
| Drug | Rgd Peptide | LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 GRN ITGB5 F10 FBN2 EGF FURIN ENTPD3 TNR | 4.88e-10 | 239 | 121 | 13 | CID000104802 |
| Drug | kalinin | 4.98e-10 | 55 | 121 | 8 | CID000032518 | |
| Drug | B-Ms | 5.27e-10 | 114 | 121 | 10 | CID000445091 | |
| Drug | Calcort | 1.11e-09 | 38 | 121 | 7 | CID000026709 | |
| Drug | BM165 | 1.76e-09 | 11 | 121 | 5 | CID003352881 | |
| Drug | DB04780 | 1.82e-09 | 170 | 121 | 11 | CID005459389 | |
| Drug | LMWH | NID2 HSPG2 LAMA1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 NR3C1 F7 LDLR F10 FBLN2 PROZ EGF LRP2 TNR PROC EPHA4 | 2.21e-09 | 663 | 121 | 19 | CID000000772 |
| Drug | Sikvav | 2.47e-09 | 24 | 121 | 6 | CID005487517 | |
| Drug | AC1L1C2F | 7.41e-09 | 110 | 121 | 9 | CID000001711 | |
| Drug | AC1L1B58 | 8.55e-09 | 29 | 121 | 6 | CID000001288 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.06e-08 | 155 | 121 | 10 | 6817_DN | |
| Drug | Grgds | 1.42e-08 | 83 | 121 | 8 | CID000123811 | |
| Drug | 2,4-diaminopyrimidine | 1.45e-08 | 54 | 121 | 7 | CID000067431 | |
| Drug | 1,2-dimethylhydrazine | 1.89e-08 | 86 | 121 | 8 | CID000001322 | |
| Drug | CC270 | 2.73e-08 | 59 | 121 | 7 | CID006918852 | |
| Drug | AC1L9INI | 2.73e-08 | 59 | 121 | 7 | CID000445839 | |
| Drug | Ikvav | 4.78e-08 | 38 | 121 | 6 | CID000131343 | |
| Drug | mespirenone | 5.23e-08 | 8 | 121 | 4 | CID000065660 | |
| Drug | pyrachlostrobin | NID2 HSPG2 EFEMP2 LAMA5 LAMB2 LAMC1 GRN ITGB5 STAB1 NTN4 SCUBE1 FBLN2 LRP2 LTBP1 LTBP2 NOTCH1 MEGF10 NOTCH2 NOTCH3 | 5.59e-08 | 811 | 121 | 19 | ctd:C513428 |
| Drug | ALT-711 | 7.42e-08 | 21 | 121 | 5 | CID000216304 | |
| Drug | Alcohol, 8 | 1.46e-07 | 3 | 121 | 3 | CID011213029 | |
| Drug | Methyl ether, 9 | 1.46e-07 | 3 | 121 | 3 | CID011155441 | |
| Drug | secondary alcohol, 15 | 1.46e-07 | 3 | 121 | 3 | CID011752649 | |
| Drug | Oxime, 22 | 1.46e-07 | 3 | 121 | 3 | CID011282904 | |
| Drug | A0395 | 1.48e-07 | 75 | 121 | 7 | CID009906466 | |
| Drug | 2-amino-5-methylpyridine | 1.78e-07 | 77 | 121 | 7 | CID000015348 | |
| Drug | YIGSR | 2.12e-07 | 79 | 121 | 7 | CID000123977 | |
| Drug | Tapi | 2.32e-07 | 80 | 121 | 7 | CID003035404 | |
| Drug | Norethindrone | 2.87e-07 | 27 | 121 | 5 | ctd:D009640 | |
| Drug | chondroitin sulfate | SELL HSPG2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 FBLN2 EGF CSPG5 LTBP1 TNR PROC | 3.18e-07 | 413 | 121 | 13 | CID000024766 |
| Drug | NSC 714187 | 3.52e-07 | 85 | 121 | 7 | CID005288693 | |
| Drug | Menadione | 5.23e-07 | 13 | 121 | 4 | DB00170 | |
| Drug | Fluticasone Propionate | 5.83e-07 | 4 | 121 | 3 | DB00588 | |
| Drug | estradiol, norethindrone drug combination | 5.83e-07 | 4 | 121 | 3 | ctd:C418365 | |
| Drug | LG 5 | 7.88e-07 | 60 | 121 | 6 | CID011840957 | |
| Drug | Xyl-Glc | 9.90e-07 | 15 | 121 | 4 | CID003083150 | |
| Drug | dalcetrapib | 9.90e-07 | 15 | 121 | 4 | ctd:C411602 | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.11e-06 | 197 | 121 | 9 | 5865_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.16e-06 | 198 | 121 | 9 | 3761_DN | |
| Drug | AC1O0B8G | 1.42e-06 | 262 | 121 | 10 | CID000091605 | |
| Drug | hyaluronan | 1.46e-06 | 263 | 121 | 10 | CID000024759 | |
| Drug | promegestone | 1.48e-06 | 37 | 121 | 5 | CID000036709 | |
| Drug | Rgds Peptide | 1.59e-06 | 106 | 121 | 7 | CID000107775 | |
| Drug | dihydro-vitamin K1 | 1.71e-06 | 17 | 121 | 4 | CID005189703 | |
| Drug | I-Q-S | 1.90e-06 | 156 | 121 | 8 | CID000003540 | |
| Drug | beta-hydroxyasparagine | 1.94e-06 | 39 | 121 | 5 | CID000152191 | |
| Drug | reduced vitamin K | 2.19e-06 | 18 | 121 | 4 | CID000124102 | |
| Drug | dysprosium | 2.74e-06 | 74 | 121 | 6 | CID000023912 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.76e-06 | 164 | 121 | 8 | 3852_UP | |
| Drug | dermatan sulfate | 2.76e-06 | 220 | 121 | 9 | CID000032756 | |
| Drug | 3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide | 2.89e-06 | 6 | 121 | 3 | ctd:C101850 | |
| Drug | 18-VP | 2.89e-06 | 6 | 121 | 3 | CID000133557 | |
| Drug | 18EP | 2.89e-06 | 6 | 121 | 3 | CID003082761 | |
| Drug | quinaprilat | 3.20e-06 | 43 | 121 | 5 | CID000107994 | |
| Drug | 8-Bromo Cyclic Adenosine Monophosphate | NID2 DNER NR4A2 LAMA3 LAMB3 NR4A3 NR4A1 NR3C1 LDLR PGR EGF JAG1 NR3C2 NR1I3 NOTCH3 | 4.18e-06 | 693 | 121 | 15 | ctd:D015124 |
| Drug | AC1L9Q7L | 4.24e-06 | 21 | 121 | 4 | CID000452291 | |
| Drug | Vanadates | HSPG2 LAMA1 DNER LAMB1 LAMB3 LAMC1 GRN E2F5 EPGN SLC40A1 ITGB5 ZFAND4 PGR ZCCHC14 NTN4 ITGBL1 EGF JAG1 NR3C2 LTBP1 LTBP2 | 4.77e-06 | 1302 | 121 | 21 | ctd:D014638 |
| Drug | Implanon | 5.01e-06 | 47 | 121 | 5 | CID000040976 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 5.02e-06 | 302 | 121 | 10 | ctd:D003633 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 5.38e-06 | 83 | 121 | 6 | CID011968896 | |
| Drug | lead stearate | 5.76e-06 | 84 | 121 | 6 | CID000061258 | |
| Drug | AC1L2E0P | 5.80e-06 | 307 | 121 | 10 | CID000019390 | |
| Drug | enzacamene | 5.88e-06 | 129 | 121 | 7 | ctd:C038939 | |
| Drug | isocycloheximide | LAMA1 NR4A2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC1 NR4A1 NR3C1 KDM6B LRP1B LDLR PGR EGF LRP2 LRP6 NR3C2 | 6.05e-06 | 905 | 121 | 17 | CID000002900 |
| Drug | poly-N-acetyllactosamine | 7.55e-06 | 88 | 121 | 6 | CID000119547 | |
| Drug | H-9 dihydrochloride | 8.60e-06 | 90 | 121 | 6 | CID000003544 | |
| Drug | octylmethoxycinnamate | 9.61e-06 | 139 | 121 | 7 | ctd:C118580 | |
| Drug | trypanothione disulfide | 1.01e-05 | 140 | 121 | 7 | CID000115098 | |
| Drug | Gestodene | 1.04e-05 | 26 | 121 | 4 | ctd:C033273 | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 5974_UP | |
| Drug | mono-(2-ethylhexyl)phthalate | PLB1 ZAN NR4A2 NR4A3 MUC5B NR4A1 F10 CD163 FBLN2 EGF CHD5 ADAMTS20 LTBP1 NR1I3 | 1.08e-05 | 658 | 121 | 14 | ctd:C016599 |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 1.10e-05 | 198 | 121 | 8 | 6748_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.14e-05 | 199 | 121 | 8 | 3570_UP | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.14e-05 | 199 | 121 | 8 | 3306_UP | |
| Drug | BMS-186282 | 1.18e-05 | 95 | 121 | 6 | CID000002416 | |
| Drug | CDRI-85/287 | 1.63e-05 | 29 | 121 | 4 | CID000159508 | |
| Drug | monatepil | 1.63e-05 | 29 | 121 | 4 | CID000060810 | |
| Drug | VTEs | 1.71e-05 | 10 | 121 | 3 | CID000006516 | |
| Drug | AC1LA234 | 1.71e-05 | 10 | 121 | 3 | CID000480136 | |
| Drug | Chlorogenic Acid | 1.87e-05 | 103 | 121 | 6 | ctd:D002726 | |
| Drug | AC1L3MCS | 1.87e-05 | 30 | 121 | 4 | CID000091577 | |
| Drug | rhamnose | 2.09e-05 | 356 | 121 | 10 | CID000000840 | |
| Drug | butylparaben | 2.12e-05 | 157 | 121 | 7 | ctd:C038091 | |
| Drug | 3,4,3',4'-tetrachloroazobenzene | 2.34e-05 | 11 | 121 | 3 | ctd:C013279 | |
| Drug | 6-amino-1-naphthalenesulfonamide | 2.34e-05 | 11 | 121 | 3 | CID000071009 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.49e-05 | 161 | 121 | 7 | 3556_DN | |
| Drug | Gdrgdsp | 2.58e-05 | 109 | 121 | 6 | CID000115346 | |
| Drug | Megestrol | 2.80e-05 | 2 | 121 | 2 | DB00351 | |
| Drug | Flumethasone | 2.80e-05 | 2 | 121 | 2 | ctd:D005443 | |
| Drug | SureCN3012010 | 2.80e-05 | 2 | 121 | 2 | CID009861044 | |
| Drug | CHEMBL227088 | 2.80e-05 | 2 | 121 | 2 | CID009885493 | |
| Drug | H-gpt-1 | 2.80e-05 | 2 | 121 | 2 | CID000190908 | |
| Drug | SureCN3023194 | 2.80e-05 | 2 | 121 | 2 | CID009905296 | |
| Drug | Mifepristone | 2.80e-05 | 2 | 121 | 2 | DB00834 | |
| Drug | CycloProvera | 2.80e-05 | 2 | 121 | 2 | ctd:C034528 | |
| Drug | 4-hydroxy-2',4',6'-trichlorobiphenyl | 2.80e-05 | 2 | 121 | 2 | ctd:C105195 | |
| Drug | AC1L2X7C | 2.80e-05 | 2 | 121 | 2 | CID000104633 | |
| Drug | prednylidene | 2.80e-05 | 2 | 121 | 2 | ctd:C036266 | |
| Drug | tosyl azide | 2.80e-05 | 2 | 121 | 2 | CID000013661 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.07e-22 | 46 | 130 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P LRP2 USP17L22 USP17L15 USP17L13 | 9.22e-22 | 69 | 130 | 15 | DOID:1682 (implicated_via_orthology) |
| Disease | Glioblastoma | 1.39e-06 | 79 | 130 | 6 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.00e-06 | 84 | 130 | 6 | C0334588 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.89e-06 | 7 | 130 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.89e-06 | 7 | 130 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | Schizophrenia | RELN LAMA1 NR4A2 NTNG1 GRN CHD4 NR3C1 CD163 TXNDC5 CSPG5 JAG1 CNTNAP2 LRP2 MEGF10 SDHA | 8.48e-06 | 883 | 130 | 15 | C0036341 |
| Disease | Glioblastoma Multiforme | 1.01e-05 | 111 | 130 | 6 | C1621958 | |
| Disease | coagulation factor XA measurement | 1.34e-05 | 11 | 130 | 3 | EFO_0020266 | |
| Disease | Hepatic ductular hypoplasia | 1.93e-05 | 2 | 130 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.93e-05 | 2 | 130 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 1.93e-05 | 2 | 130 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.93e-05 | 2 | 130 | 2 | C1956125 | |
| Disease | Alagille Syndrome | 1.93e-05 | 2 | 130 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.93e-05 | 2 | 130 | 2 | cv:C0085280 | |
| Disease | Autistic Disorder | 2.16e-05 | 261 | 130 | 8 | C0004352 | |
| Disease | coagulation factor X measurement | 2.31e-05 | 13 | 130 | 3 | EFO_0020265 | |
| Disease | Junctional epidermolysis bullosa | 5.76e-05 | 3 | 130 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 5.76e-05 | 3 | 130 | 2 | cv:C0079683 | |
| Disease | cutis laxa (implicated_via_orthology) | 5.76e-05 | 3 | 130 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 5.76e-05 | 3 | 130 | 2 | 226700 | |
| Disease | Carcinoma of bladder | 6.50e-05 | 18 | 130 | 3 | C0699885 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 6.54e-05 | 49 | 130 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | MKRN3 LAMA1 OBSCN NR4A2 NTNG1 LAMB3 LAMC1 FBLN2 FBN2 CHD5 LRP2 NR3C2 | 6.69e-05 | 702 | 130 | 12 | C0009402 |
| Disease | Endometrioma | 8.21e-05 | 161 | 130 | 6 | C0269102 | |
| Disease | Endometriosis | 8.21e-05 | 161 | 130 | 6 | C0014175 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.91e-05 | 53 | 130 | 4 | C4707243 | |
| Disease | Major Depressive Disorder | 1.05e-04 | 243 | 130 | 7 | C1269683 | |
| Disease | Herlitz Disease | 1.15e-04 | 4 | 130 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.15e-04 | 4 | 130 | 2 | C0079297 | |
| Disease | laminin measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0020528 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.58e-04 | 24 | 130 | 3 | C0887833 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.91e-04 | 5 | 130 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.91e-04 | 5 | 130 | 2 | C2608084 | |
| Disease | myotonic dystrophy type 2 (implicated_via_orthology) | 1.91e-04 | 5 | 130 | 2 | DOID:0050759 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.91e-04 | 5 | 130 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | brain cancer (implicated_via_orthology) | 2.02e-04 | 26 | 130 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Cutis Laxa | 2.86e-04 | 6 | 130 | 2 | C0010495 | |
| Disease | Junctional Epidermolysis Bullosa | 2.86e-04 | 6 | 130 | 2 | C0079301 | |
| Disease | Malformation of cortical development | 2.86e-04 | 6 | 130 | 2 | cv:C1955869 | |
| Disease | Lissencephaly | 2.86e-04 | 6 | 130 | 2 | cv:C0266463 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.93e-04 | 131 | 130 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.93e-04 | 131 | 130 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 2.93e-04 | 131 | 130 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 2.93e-04 | 131 | 130 | 5 | C3714758 | |
| Disease | colorectal cancer (implicated_via_orthology) | 3.11e-04 | 30 | 130 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Juvenile-Onset Still Disease | 3.37e-04 | 135 | 130 | 5 | C0087031 | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.77e-04 | 32 | 130 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.99e-04 | 7 | 130 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 3.99e-04 | 7 | 130 | 2 | C0399367 | |
| Disease | Disseminated Intravascular Coagulation | 3.99e-04 | 7 | 130 | 2 | C0012739 | |
| Disease | temporal arteritis (is_marker_for) | 3.99e-04 | 7 | 130 | 2 | DOID:13375 (is_marker_for) | |
| Disease | Manic | 3.99e-04 | 78 | 130 | 4 | C0338831 | |
| Disease | cortical thickness | HSPG2 RELN LAMA1 LAMC1 ITGB5 STAB1 SCUBE1 FBN2 MALRD1 MEGF9 FURIN JAG1 ADAMTS20 EPHA4 | 4.08e-04 | 1113 | 130 | 14 | EFO_0004840 |
| Disease | Prostatic Neoplasms | 4.14e-04 | 616 | 130 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.14e-04 | 616 | 130 | 10 | C0376358 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.39e-04 | 80 | 130 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Scoliosis, unspecified | 5.30e-04 | 8 | 130 | 2 | C0036439 | |
| Disease | serum IgG glycosylation measurement | 5.34e-04 | 523 | 130 | 9 | EFO_0005193 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 6.80e-04 | 9 | 130 | 2 | C4225275 | |
| Disease | rectum cancer | 8.46e-04 | 42 | 130 | 3 | EFO_1000657 | |
| Disease | autistic disorder (is_implicated_in) | 8.46e-04 | 42 | 130 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.47e-04 | 447 | 130 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 8.47e-04 | 447 | 130 | 8 | C3714756 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 8.74e-04 | 96 | 130 | 4 | EFO_0009369 | |
| Disease | Adenoid Cystic Carcinoma | 1.02e-03 | 100 | 130 | 4 | C0010606 | |
| Disease | pulmonary fibrosis | 1.03e-03 | 11 | 130 | 2 | EFO_0009448 | |
| Disease | Marfan Syndrome | 1.03e-03 | 11 | 130 | 2 | C0024796 | |
| Disease | Unipolar Depression | 1.04e-03 | 259 | 130 | 6 | C0041696 | |
| Disease | triacylglycerol 58:12 measurement | 1.24e-03 | 12 | 130 | 2 | EFO_0010439 | |
| Disease | Thromboembolism | 1.24e-03 | 12 | 130 | 2 | C0040038 | |
| Disease | autistic disorder (is_marker_for) | 1.24e-03 | 12 | 130 | 2 | DOID:12849 (is_marker_for) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.41e-03 | 50 | 130 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | hyperglycemia (is_marker_for) | 1.46e-03 | 13 | 130 | 2 | DOID:4195 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.46e-03 | 13 | 130 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 1.46e-03 | 277 | 130 | 6 | C0009404 | |
| Disease | factor VII measurement | 1.85e-03 | 55 | 130 | 3 | EFO_0004619 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.95e-03 | 15 | 130 | 2 | C0496930 | |
| Disease | caffeine measurement | 1.95e-03 | 15 | 130 | 2 | EFO_0021177 | |
| Disease | Benign neoplasm of bladder | 1.95e-03 | 15 | 130 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.95e-03 | 15 | 130 | 2 | C0154091 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 1.95e-03 | 15 | 130 | 2 | EFO_0010367 | |
| Disease | polyp of colon | 1.95e-03 | 56 | 130 | 3 | MONDO_0021400 | |
| Disease | colorectal cancer (is_implicated_in) | 2.05e-03 | 121 | 130 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | endometriosis (biomarker_via_orthology) | 2.22e-03 | 16 | 130 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | dual specificity mitogen-activated protein kinase kinase 2 measurement | 2.22e-03 | 16 | 130 | 2 | EFO_0008112 | |
| Disease | Abnormal behavior | 2.22e-03 | 16 | 130 | 2 | C0233514 | |
| Disease | Malignant neoplasm of skin | 2.27e-03 | 59 | 130 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.27e-03 | 59 | 130 | 3 | C0037286 | |
| Disease | Mammary Carcinoma, Human | 2.33e-03 | 525 | 130 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.33e-03 | 525 | 130 | 8 | C1257931 | |
| Disease | eosinophil count | SELL PLB1 ZNF585A EFEMP2 NR3C1 KDM6B LECT2 ZNF585B CNBP JAG1 LTBP2 LTBP4 MUC5AC NOTCH1 NOTCH2 | 2.36e-03 | 1488 | 130 | 15 | EFO_0004842 |
| Disease | Insulin Resistance | 2.38e-03 | 60 | 130 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 2.38e-03 | 60 | 130 | 3 | C0920563 | |
| Disease | Mammary Neoplasms | 2.39e-03 | 527 | 130 | 8 | C1458155 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.50e-03 | 61 | 130 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Dementia | 2.51e-03 | 17 | 130 | 2 | C0497327 | |
| Disease | major depressive disorder (is_implicated_in) | 2.51e-03 | 17 | 130 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | lupus nephritis (is_marker_for) | 2.51e-03 | 17 | 130 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | mood instability measurement | 2.52e-03 | 128 | 130 | 4 | EFO_0008475 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EAVTSNHDGGCDCYV | 181 | Q7L8C5 | |
| NHDGGCDCYVQGSVA | 186 | Q7L8C5 | |
| YECNECGKGFNRSTH | 326 | Q9HBT8 | |
| LEDHNSYCINGACAF | 61 | Q6UW88 | |
| DGHACSVAVHQACYG | 26 | P55198 | |
| CHNGGQCYLVENIGA | 381 | O95196 | |
| DHQDYCEVCQQGGEI | 341 | Q8TDI0 | |
| EDRQHCCPAGYTCNV | 476 | P28799 | |
| KICDVNHRDNAGYCA | 1486 | Q6W2J9 | |
| CYDRHIGVDCSDGFN | 651 | O14525 | |
| EDCECDNGHLAAGYT | 1786 | P59510 | |
| ACHDQETCSFDGVYQ | 346 | O75355 | |
| CTAVAAYAQACHDAG | 1126 | Q9HC84 | |
| DNCTVYLCEAEGGVH | 5611 | Q9HC84 | |
| LDQSCQGTYICQAHG | 3456 | P98160 | |
| VHNIGQGCVSCLDYD | 536 | Q96SU4 | |
| RCAVCGDNASCQHYG | 266 | P22736 | |
| GDNASCQHYGVRTCE | 271 | P22736 | |
| RCEQGTYGNDCHQRC | 181 | Q96KG7 | |
| TYGNDCHQRCQCQNG | 186 | Q96KG7 | |
| CVVCGDQATGYHFNA | 11 | Q14994 | |
| HGQCQDGIDSYTCIC | 581 | Q04721 | |
| GNGPHHDRCCTYNEN | 101 | O95278 | |
| HDRCCTYNENNLVDG | 106 | O95278 | |
| GYEGVHCEVNTDECA | 481 | P46531 | |
| PCRHGGTCQDRDNAY | 611 | P46531 | |
| VHGACRDSLNGYKCD | 726 | P46531 | |
| CVAGYHGVNCSEEID | 1171 | P46531 | |
| GYDEGVHCQELLSNC | 106 | Q9NZR2 | |
| GSDEVGCVHSCFDNQ | 996 | Q9NZR2 | |
| VEGQHNYLCAGRNDC | 631 | P08235 | |
| VNADGSYLCQCHEGF | 336 | O00339 | |
| HGCEHICVNNGNSYI | 616 | O00339 | |
| RAIDYCSFGNHSCQH | 296 | O95460 | |
| DHGCEFQCVSEGLSY | 346 | O95460 | |
| AGEHCERCQEGYYGN | 1711 | Q16787 | |
| ENGSRNTYLVHCEGC | 1591 | O15054 | |
| HEERSGECQACKIGY | 266 | P54764 | |
| EGQVCHNLPGSYRCD | 871 | P98095 | |
| CDQGYRASGLGDHCE | 1146 | Q14766 | |
| QAGGQCVDEDSSHYC | 1056 | Q9UM47 | |
| ADHFADGRCDQGCNT | 1476 | Q9UM47 | |
| HCQRGYQGDGISHCN | 1101 | Q7Z7M0 | |
| YQGDGISHCNRTCLE | 1106 | Q7Z7M0 | |
| CDRHGCGQYSAQRSQ | 36 | O14960 | |
| EYRQHPCAQDNGGCS | 1201 | O75581 | |
| SGHGECVEIINNYTC | 166 | P14151 | |
| NCLEGYVHDLEGNCI | 436 | Q9H1U4 | |
| VTGQCHCFQGVYARQ | 836 | P07942 | |
| NYLGTVQEHCNGSDC | 1031 | P07942 | |
| ELVVRGNCFCYGHAS | 276 | P55268 | |
| GQHNYLCAGRNDCII | 451 | P04150 | |
| CDNNRCIYSHEVCNG | 3891 | P98164 | |
| EDCPCVHNEASYRAG | 861 | P98088 | |
| FNGDCEYTLVQNHCG | 921 | P98088 | |
| TYQGGGVCIDCQHHT | 386 | O15230 | |
| NTEGAHCERCQAGFV | 1886 | O15230 | |
| FCGNNVISHFYCDVG | 166 | Q8NH79 | |
| CHAGYIGDNCNCSTD | 576 | P18084 | |
| HQCENIFREGQYFGC | 171 | P78552 | |
| GSCDHGICRCDQGYQ | 1041 | P78509 | |
| GICRCDQGYQGTECH | 1046 | P78509 | |
| RCEFADQGVYVCDAH | 2226 | Q5VST9 | |
| GRNCVDENECATGFH | 796 | Q14112 | |
| SLDNGGCTHYCLEEV | 141 | P04070 | |
| EGQHNYLCAGRNDCI | 596 | P06401 | |
| DQCGDSSDERHCLNY | 56 | Q5VYJ5 | |
| QRGQAGEYECVTHNG | 186 | A6NGN9 | |
| SYVTHEDICNCFNGD | 171 | Q15329 | |
| GACGRTVYHAEEVQC | 11 | Q16527 | |
| VCRCSEGYQGDGIHC | 896 | P01133 | |
| CQAGFSGRHCDDNVD | 431 | O00548 | |
| CDHCSFRGTDYENVQ | 16 | Q96JM3 | |
| TDHQDYCEVCQQGGE | 376 | Q12873 | |
| EVDTCRGHYNNVSCA | 241 | P53621 | |
| GGREHDSCNCDGYTN | 296 | P09958 | |
| ACENGECVNTEGSFH | 1536 | Q14767 | |
| ALGQTCRYFHEVCDG | 61 | O75426 | |
| GNCTRGENDCRYAHP | 186 | Q9NUK0 | |
| SGAECYACIGVHQDD | 131 | Q6UWN5 | |
| YACIGVHQDDCAIGR | 136 | Q6UWN5 | |
| CDQGYEGARDGRHCV | 1076 | Q8N2S1 | |
| QGAYGGVCDNCRDHT | 336 | Q13751 | |
| TGQHCERCEVNHFGF | 961 | P11047 | |
| GTNCENGGKCLERYH | 971 | Q9UHC6 | |
| NVCSHGLCVDLQGSY | 1901 | P35556 | |
| CTDDVRPQDCYHGAG | 361 | P26927 | |
| HEEQNSVVCSCARGY | 141 | P00742 | |
| EAQTCVNFHGGYRCV | 296 | O95967 | |
| VNFHGGYRCVDTNRC | 301 | O95967 | |
| GKHYCNHNEDAGVTC | 351 | Q86VB7 | |
| ETDHQDYCEVCQQGG | 366 | Q14839 | |
| ECISGYAREHGQCAD | 276 | Q6UXH1 | |
| YAREHGQCADVDECS | 281 | Q6UXH1 | |
| NNGTCYVDGVHFTCN | 441 | Q8NFT8 | |
| GGCDHFCRNTVGSFE | 291 | Q8IWY4 | |
| DRYSDDFCSGHGQCN | 281 | O95965 | |
| TVENGYLHQDCCASA | 266 | Q5T953 | |
| CHNGGTCRDLVNDFY | 676 | P78504 | |
| ARCECHVGYQLAADG | 266 | O75095 | |
| QACPAGLYGDNCRHS | 1031 | O75095 | |
| GLYGDNCRHSCLCQN | 1036 | O75095 | |
| GLCAVCGDNAACQHY | 261 | P43354 | |
| CGDNAACQHYGVRTC | 266 | P43354 | |
| TCAVCGDNAACQHYG | 291 | Q92570 | |
| GDNAACQHYGVRTCE | 296 | Q92570 | |
| IGNCECFGHSNRCSY | 361 | Q9Y2I2 | |
| YACECQEGGAAHVVA | 626 | O95754 | |
| GAQHQREACPSYATC | 3456 | A2VEC9 | |
| CQGYGFEVLDCHQFS | 791 | A2VDJ0 | |
| YACGEAACASVHGAN | 436 | P31040 | |
| GGVCDDCQHNTEGQY | 356 | Q9HB63 | |
| CVNENGGCEQYCSDH | 151 | P08709 | |
| HDNVREYLCAECGKG | 1106 | P57071 | |
| NTDGAHCERCADGFY | 876 | P25391 | |
| HCERCADGFYGDAVT | 881 | P25391 | |
| DHNRQRGCCGSLADY | 6 | Q9NP59 | |
| SCAQGYRLGEDHKQC | 151 | P22891 | |
| GGNDLCDFCNDLVHY | 511 | Q6P1J6 | |
| RPGVECYCQHDSGAA | 86 | Q5T5C0 | |
| AANGHCIDIYACALD | 341 | Q15437 | |
| GVDCYCQHESGAAVL | 101 | Q9Y2K9 | |
| EDACYNCGRGGHIAK | 71 | P62633 | |
| YECQECGRAFSQGGH | 246 | Q86YE8 | |
| HGQCKEGENCRYSHD | 106 | Q13064 | |
| DYEIHCDLNGCGQIF | 1441 | Q13129 | |
| LEHGADIYQNCCEAF | 196 | Q9H0I9 | |
| LNGENAYHCGVCLQR | 246 | D6R9N7 | |
| GYVGEDCGQRQCLNA | 286 | Q92752 | |
| LNGENAYHCGVCLQR | 246 | A8MUK1 | |
| EYGCDLTCNHGGCQE | 106 | Q96DN2 | |
| LNGENAYHCGVCLQR | 246 | D6R901 | |
| LNGENAYHCGVCLQR | 246 | C9JLJ4 | |
| GERQYECHECGKAFN | 546 | Q52M93 | |
| NTRRCECHAGYVGDG | 2156 | Q9NY15 | |
| ECHAGYVGDGLQCLE | 2161 | Q9NY15 | |
| LNGENAYHCGVCLQR | 246 | D6RCP7 | |
| GGDGCQYCHSRTEQQ | 266 | Q9H9P5 | |
| GERQYECHECGKAFN | 546 | Q6P3V2 | |
| FQYQRIHAGEASCEC | 326 | Q96JL9 | |
| LNGENAYHCGVCLQR | 246 | C9JPN9 | |
| LSCYNCGATGHRAQD | 906 | Q8WYQ9 | |
| LNGENAYHCGVCLQR | 246 | Q0WX57 | |
| RIHSGDEAYICNECG | 501 | Q8NF99 | |
| DRFCTHNEGNQYGEA | 106 | Q68EA5 | |
| HNGERPYQCEDCGQA | 526 | Q5T619 | |
| DCTQHYELCSGNQVR | 246 | Q8NBS9 | |
| RAHFVYGIACDNGCI | 456 | Q8WUA4 | |
| LNGENAYHCGVCLQR | 246 | Q6QN14 | |
| ECRCGNNFCASHRYA | 681 | Q86XD8 | |
| NNFCASHRYAETHGC | 686 | Q86XD8 | |
| LNGENAYHCGVCLQR | 246 | D6RA61 | |
| LNGENAYHCGVCLQR | 246 | C9J2P7 | |
| LNGENAYHCGVCLQR | 246 | D6RBQ6 | |
| DGQCCALLQGHESYV | 46 | Q86TI4 | |
| LNGENAYHCGVCLQR | 246 | D6RJB6 | |
| LNGENAYHCGVCLQR | 246 | C9JJH3 | |
| LNGENAYHCGVCLQR | 246 | C9JVI0 | |
| AQEFCGQQDGIYGCH | 1521 | Q9Y493 | |
| GNCIHGSRQCDREYD | 246 | P01130 |